Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3008757	b-diffmik	— (—)	3090	10481	100.00%	Distribution not available
3008757	b-diff-mik	— (—)	1822	5197	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

L04AX Other immunosuppressants

883

2178

4.14

317.73

3.7

3.5

—

Other septicaemia

843

1128

7.46

307.65

4.4

3.3

—

Other diseases of blood and blood-forming organs, wide

553

854

6.79

307.65

6.9

3.5

—

1246

1843

4.16

307.65

4.5

3.0

—

Other bacterial diseases

1672

2087

5.19

307.65

4.3

3.0

—

Other bacterial diseases

1742

2091

5.74

307.65

4.3

3.0

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

1589

2505

4.46

307.65

5.0

2.7

—

Oral corticosteroids

1525

2256

4.08

307.65

3.7

3.4

—

Transplanted organ and tissue status

360

322

12.15

307.65

8.1

3.3

—

Pneumonias (Asthma/COPD co-morbidities)

1377

2540

3.70

307.65

4.5

3.0

—

Any gastric operation

842

759

5.63

307.65

3.8

2.4

—

GASTRO-related operations

842

759

5.63

307.65

3.8

2.4

—

Fever of other and unknown origin

1014

1777

5.20

307.65

5.3

3.1

—

Second line medication for Crohn's disease

921

2229

4.22

307.65

3.7

3.5

—

Septicaemia

919

1246

7.15

307.65

4.3

3.2

—

All pneumoniae

1384

2559

3.67

307.65

4.5

3.0

—

Bacterial infection, other or unspecified

1315

1575

7.32

307.65

4.8

3.2

—

ILD medications: prednisolone, methylprednisolone, prednisone

1568

1941

4.60

307.65

4.0

3.1

—

Bacterial infection, other or unspecified

1262

1489

7.64

307.65

4.9

3.2

—

First line medication for Crohn's disease

1608

1858

4.76

307.65

4.0

3.2

—

Explicit Sepsis

939

1573

5.76

307.65

4.4

3.5

—

Liquid cancers, helper endpoint

1198

1011

10.95

307.65

7.2

2.4

—

ILD medications

1670

1993

4.62

307.65

4.2

3.1

—

Inflammatory bowel disease treatment related agents

1613

2341

3.92

307.65

3.7

3.4

—

Oxycodone

728

1337

5.07

307.65

3.8

3.7

—

Primary_lymphoid and hematopoietic malignant neoplasms

851

896

10.21

307.65

7.4

2.9

—

ILD medications: immunosuppressive drugs

1192

1725

6.60

307.65

4.3

3.1

—

Influenza and pneumonia

1432

2502

3.70

307.65

4.5

3.0

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1339

2603

3.56

307.65

4.4

3.1

—

Pneumonia, organism unspecified

1340

2393

4.00

307.65

4.4

3.1

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1246

1843

4.16

307.65

4.5

3.0

—

Bacterial Sepsis

789

1535

4.50

300.41

4.4

3.6

—

Anaemias

367

197

12.46

287.31

4.6

1.8

—

Non-Hodgkin lymphoma, all, including Hilmo

342

373

9.69

285.84

5.7

3.0

—

Certain infectious and parasitic diseases

1080

1418

3.86

279.29

4.2

2.8

—

Lymphoid leukaemia

257

222

13.01

255.48

10.5

3.6

—

Implicit bacterial Sepsis

669

1385

4.39

249.73

4.4

3.6

—

Implicit bacterial Sepsis

700

1488

4.16

241.97

4.3

3.6

—

Agranulocytosis

308

385

8.50

231.35

6.9

3.3

—

Renal tubulo-interstitial diseases

1101

2753

3.02

227.46

3.9

3.5

—

Malignant neoplasm

986

1747

3.38

227.08

4.7

2.8

—

Malignant neoplasm, wide definition for exclusion

985

1788

3.27

215.08

4.5

2.8

—

Aplastic and other anaemias

736

1954

3.59

211.83

4.9

3.5

—

Secondary uncertain malignant neoplasm

289

374

8.08

210.18

3.9

3.2

—

Any event in cancer register

1012

1930

3.12

206.13

4.8

2.6

—

Medical observation and evaluation for suspected diseases and conditions

794

1091

3.77

201.09

3.8

3.4

—

Any death

867

1935

3.27

200.95

4.6

3.4

—

Implicit Sepsis

904

2213

3.12

198.61

4.0

3.4

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

887

2622

3.08

198.38

4.4

3.6

—

All kidney diseases

1132

2832

2.76

195.49

4.0

3.4

—

Abnormal findings on diagnostic imaging of lung

723

2076

3.41

193.84

4.4

3.6

—

Erysipelas

761

1746

3.37

189.69

3.7

3.1

—

ILD medications: azathioprine

252

315

8.25

188.18

3.8

3.0

—

Infections, IBD-co-morbidities

297

267

8.17

187.43

5.5

3.5

—

Autoimmune diseases related-to ILD

999

3108

2.78

185.37

3.2

3.6

—

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

141

22.14

184.84

11.3

3.1

—

Chronic lymphocytic leukaemia, helper endpoint

141

22.14

184.84

11.3

3.1

—

Chronic lymphocytic leukaemia

141

22.14

184.84

11.3

3.1

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

289

437

6.87

182.53

3.8

3.2

—

Non-follicular lymphoma

265

370

7.62

181.17

5.3

4.1

—

Secondary and unspecified malignant neoplasm of lymph nodes

206

212

10.27

179.88

4.4

3.2

—

L04AA Selective immunosuppressants

394

812

5.00

178.97

5.1

3.8

—

Other anaemias

653

1853

3.42

175.78

4.9

3.5

—

Other and unspecified anaemias

648

1838

3.43

175.38

4.9

3.5

—

General symptoms and signs

1108

2033

2.76

173.19

4.1

3.1

—

Renal failure

690

1880

3.31

173.19

4.5

3.7

—

Erysipelas

618

1570

3.53

172.66

3.7

3.2

—

Implicit Sepsis

911

2345

2.87

172.23

3.9

3.4

—

COPD/asthma related infections

1039

1843

2.85

172.20

4.2

3.0

—

COPD/asthma/ILD related infections

1039

1843

2.85

172.20

4.2

3.0

—

Heart failure, not strict

918

2190

2.89

171.02

4.4

3.6

—

Myelodysplastic syndrome, including Hilmo

131

21.01

168.87

11.7

3.1

—

Autoimmune diseases excluding thyroid diseases

1144

2420

2.61

165.61

3.4

3.7

—

Acute myeloid leukaemia and myelodysplastic syndromes

108

33.70

165.50

12.1

2.9

—

Autoimmune diseases excluding thyroid diseases, strict definition

1108

2348

2.61

161.18

3.4

3.7

—

Rare circulating lymphoid malignancy, including Hilmo

125

20.82

160.73

9.8

3.4

—

Azathioprine

252

377

6.89

160.53

3.8

3.9

—

Multiple myeloma, including Hilmo

151

117

14.04

159.74

5.0

3.5

—

Donors of organs and tissues

40.50

157.50

3.6

5.0

—

Complications of medical and surgical care

863

2989

2.69

152.41

4.7

3.4

—

Any reimbursement code in KELA

477

528

4.57

151.17

3.8

2.0

—

Other and unspecified disorders of skin and subcutaneous tissue

185

210

9.41

150.44

4.4

3.7

—

All chronic kidney diseases

700

1927

3.02

148.20

3.9

3.6

—

Non-Hodgkin lymphoma, all

138

106

14.07

146.59

6.8

3.5

—

Complications of surgical and medical care, not elsewhere classified

1072

3054

2.43

143.60

4.3

3.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

887

2389

2.65

142.96

3.9

3.4

—

General examination and investigation of persons without complaint and reported diagnosis

675

1090

3.27

141.50

4.0

3.4

—

Polyarthropathies

788

1849

2.82

139.41

3.5

3.7

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1020

2741

2.45

137.11

5.0

3.1

—

Dental caries

370

862

4.21

135.25

4.8

3.3

—

Certain infectious and parasitic diseases

663

1046

3.20

133.09

4.3

2.8

—

Other medical care

602

1811

3.04

132.23

4.3

3.8

—

Covid-19 confirmed case

512

1593

3.28

130.72

4.3

3.7

—

Solid cancers, helper endpoint

792

1715

2.75

130.65

3.5

2.8

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

272

546

5.16

127.76

4.7

4.0

—

Myeloid leukaemia

119

14.38

125.89

10.8

4.6

—

Implicit viral Sepsis

297

653

4.66

124.70

5.1

3.5

—

Viral Sepsis

297

654

4.65

124.46

5.1

3.5

—

L04AD Calcineurin inhibitors

225

390

6.02

124.40

6.8

3.9

—

Streptococcal septicaemia

169

217

8.10

123.75

3.8

—

Caries of dentine

331

774

4.25

122.85

4.6

3.4

—

Condition for Implicit Sepsis (Organ dysfunction codes)

874

2454

2.48

122.74

3.9

3.4

—

Persons encountering health services for specific procedures and health care

1075

2843

2.29

122.05

3.5

—

Neoplasms

679

1231

2.95

122.00

4.4

2.3

—

Diffuse large B-cell lymphoma

128

117

11.74

121.77

4.9

3.4

—

Diffuse large B-cell lymphoma, including Hilmo

128

117

11.74

121.77

4.9

3.4

—

Diffuse large B-cell lymphoma, helper endpoint

128

117

11.74

121.77

4.9

3.4

—

Enlarged lymph nodes

243

462

5.40

121.05

4.6

3.3

—

Acute renal failure

347

881

4.04

120.83

4.6

3.9

—

Multiple myeloma

102

17.37

120.51

4.3

4.1

—

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

102

17.37

120.51

4.3

4.1

—

Acute tubulo-interstitial nephritis

701

2313

2.65

118.61

3.4

—

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

316

751

4.25

117.69

2.4

3.1

—

Other pulmonary diagnosis

676

1173

2.91

116.61

4.4

2.9

—

Autoimmune diseases

1083

2436

2.28

116.55

3.5

3.7

—

Implicit viral Sepsis

369

1014

3.71

114.33

4.7

3.3

—

Excluding asthma or asthma-COPD overlap

669

1173

2.88

113.40

4.5

2.9

—

Myeloproliferative diseases

192

321

6.29

110.45

10.7

3.8

—

Other disorders of white blood cells

144

177

8.65

109.89

8.4

3.3

—

Asthma, unspecified (mode), excluding more controls

448

1016

3.33

109.76

3.4

2.9

—

Multiple myeloma and malignant plasma cell neoplasms

151

199

8.19

109.10

5.0

4.5

—

All influenza

319

829

3.92

107.19

5.1

3.4

—

Asthma, unspecified (mode)

464

1101

3.20

107.13

3.3

2.9

—

Chronic kidney disease

435

1355

3.21

107.01

4.4

3.7

—

Tramadol

738

1791

2.55

107.01

3.4

3.5

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

667

2625

2.54

106.77

4.7

3.4

—

ILD differential diagnosis

663

1198

2.79

106.70

4.5

2.9

—

COPD differential diagnosis

663

1200

2.79

106.40

4.5

2.9

—

Purpura and other haemorrhagic conditions

240

512

4.84

104.96

6.6

3.9

—

Explicit bacterial Sepsis

187

319

6.06

104.90

4.4

3.9

—

Reimbursement for rheumatic diseases

628

2447

2.59

104.79

3.1

3.7

—

COPD (mode)

342

713

3.83

103.78

3.1

3.2

—

Other bacterial intestinal infections

280

684

4.20

102.80

4.7

4.2

—

Used for control exclusion in common control thyroid runs

996

2267

2.24

102.62

3.7

3.6

—

Thrombocytopenia, unspecified

168

267

6.62

101.69

7.1

3.6

—

Systemic connective tissue disorders

448

1496

3.05

101.54

3.3

3.7

—

Sulfasalazine

311

827

3.82

101.09

2.8

3.7

—

Hernia of abdominal wall, postoperative

172

279

6.26

101.08

3.5

2.8

—

Other and unspecified disorders of white blood cells

120

131

9.84

100.73

9.2

3.4

—

Drug-induced neutropenia

163

254

6.75

100.58

4.8

3.9

—

Iron deficiency anaemia

520

1875

2.77

99.14

4.4

3.5

—

L01XX Other antineoplastic agents

153

228

7.14

98.76

11.4

3.9

—

Continuous positive airway pressure

280

574

4.20

97.88

3.1

3.8

—

Care involving dialysis

164

264

6.49

97.86

3.5

4.6

—

Bacterial intestinal infections, IBD co-morbidities

279

706

4.05

97.66

4.9

4.1

—

Nutritional anaemias

582

2186

2.60

97.42

4.4

3.5

—

Budesonide

185

336

5.63

96.94

3.0

3.9

—

Provisional assignment of new diseases of uncertain etiology

588

2322

2.56

96.06

4.3

3.4

—

Codes for special purposes

588

2327

2.55

95.63

4.3

3.4

—

Fitting and adjustment of other devices

455

1420

2.94

94.61

3.6

3.9

—

6-mercaptopurine

13.64

94.58

5.0

3.0

—

Enterocolitis due to Clostridium difficile

199

399

5.16

93.74

5.5

4.0

—

Dialysis, with operation codes

215

464

4.78

92.77

4.3

3.9

—

Secondary hypertension

145

213

6.96

92.67

3.5

3.6

—

Viral pneumonia

194

386

5.16

91.98

4.9

3.6

—

Myeloproliferative diseases (CML excluded)

167

293

5.98

91.46

10.6

3.8

—

Coagulation defects, purpura and other haemorrhagic conditions

283

762

3.80

90.74

6.0

3.8

—

Biological medication for rheuma

230

537

4.38

89.61

2.7

4.0

—

Myelodysplastic syndrome

33.68

88.52

14.3

3.5

—

Rheumatoid arthritis

386

1132

3.10

88.35

3.1

3.8

—

Failure and rejection of transplanted organs and tissues

17.01

88.02

15.5

3.8

—

Osteopathies and chondropathies

596

2310

2.43

86.16

3.8

3.7

—

Opioids

834

1962

2.22

85.67

3.8

3.4

—

Other bacterial intestinal infections

304

895

3.46

85.10

4.6

4.0

—

Oedema, not elsewhere classified

350

1113

3.15

84.01

3.6

3.4

—

Complications of procedures, not elsewhere classified

769

2952

2.17

83.86

3.7

3.4

—

5-aminosalicylic acid

228

556

4.17

83.72

3.3

3.9

—

Intestinal infectious diseases

901

3377

2.04

81.83

3.9

3.5

—

Other special examinations and investigations of persons without complaint or reported diagnosis

563

1091

2.63

81.83

4.5

3.4

—

Other and unspecified iron deficiency

399

1423

2.85

80.22

4.1

3.6

—

Lung cancer and mesothelioma

229

479

4.17

80.14

2.8

3.5

—

1033

2701

1.99

79.98

4.2

3.4

—

Nephropathy related operations

202

471

4.42

79.18

4.5

4.3

—

Seropositive rheumatoid arthritis

303

934

3.29

78.21

3.2

3.9

—

Bronchitis

987

3185

1.96

77.66

4.3

3.3

—

Polycythaemia vera

11.94

77.45

9.8

3.2

—

Other diseases of pleura

535

1945

2.44

77.14

4.4

3.7

—

Other systemic involvement of connective tissue (FG)

296

905

3.28

76.07

3.1

3.8

—

IBD patients in KELA-register

269

792

3.45

75.28

3.2

4.0

—

Heart failure,strict

554

1629

2.43

75.07

4.4

3.7

—

Tumor necrosis factor alpha inhibitors

200

481

4.25

75.03

2.8

3.9

—

Nausea and vomiting

329

1072

3.05

74.83

3.8

3.7

—

Diarrhoea and gastroenteritis of presumed infectious origin

681

2860

2.16

74.64

3.5

—

Dyspnoea

849

3133

2.02

74.51

3.8

3.6

—

Malaise and fatigue

477

1518

2.55

74.43

3.6

3.3

—

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

219

567

3.94

74.28

2.3

3.1

—

Acute myeloid leukaemia, including Hilmo

27.19

73.81

9.5

4.6

—

Acute myeloid leukaemia, helper endpoint

27.19

73.81

9.5

4.6

—

Acute myeloid leukaemia

27.19

73.81

9.5

4.6

—

Inflammatory bowel disease, strict (require KELA)

269

809

3.38

72.82

3.2

4.0

—

Extracorporeal dialysis

133

236

5.91

72.09

3.3

4.1

—

Asthma, excluding more controls

522

1076

2.55

72.03

3.1

2.9

—

Osteoporosis

323

1012

3.04

71.80

3.8

—

Noninfective enteritis and colitis

491

2050

2.42

71.38

3.6

3.7

—

Finngen Rheumatological endpoints

822

2293

2.05

71.18

3.6

3.7

—

Other symptoms and signs involving the digestive system and abdomen

220

595

3.77

70.13

3.9

—

Codeine

743

1918

2.12

68.98

3.7

3.4

—

Asthma

540

1168

2.44

68.48

3.2

2.9

—

Methotrexate

166

371

4.56

68.45

3.2

4.0

—

Crohn disease

174

404

4.41

68.44

3.0

4.4

—

Inflammatory bowel disease

344

1238

2.82

68.15

3.3

4.0

—

Early onset COPD, excluding more controls

206

542

3.86

68.12

3.2

3.1

—

Preparatory care for dialysis

108

166

6.90

67.78

3.3

4.6

—

Other disorders of skin and subcutaneous tissue

674

2894

2.09

67.28

4.1

3.6

—

Gastro-oesophageal reflux disease

650

2672

2.12

66.95

3.6

3.7

—

Diseases of oesophagus, stomach and duodenum

939

2966

1.91

66.91

3.7

3.6

—

Parasetamol

592

1303

2.32

66.55

3.5

3.6

—

Abnormalities of breathing

795

2300

2.02

66.51

3.6

3.3

—

Other disorders of fluid, electrolyte and acid-base balance

375

1355

2.68

66.42

3.5

3.9

—

Asthma (only as main-diagnosis), excluding more controls

471

1076

2.52

65.55

3.3

2.9

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

568

2623

2.18

65.05

3.9

3.7

—

Follow-up examination after treatment for conditions other than malignant neoplasms

361

857

2.81

64.59

3.3

—

DVT of lower extremities and pulmonary embolism

449

1898

2.38

63.18

4.3

3.7

—

Hypothyroidism (congenital or acquired)

175

205

4.86

63.09

3.7

1.8

—

Persons encountering health services in other circumstances

415

1694

2.46

62.91

3.3

3.6

—

Fentanyl

146

315

4.74

62.86

4.3

4.5

—

Symptoms and signs involving the urinary system

733

2824

1.99

62.70

3.8

3.7

—

Asthma (only as main-diagnosis)

485

1168

2.42

62.33

3.3

2.9

—

Acute upper respiratory infections of multiple and unspecified sites

666

2414

2.06

62.04

4.3

3.3

—

Acute lymphocytic leukaemia, including Hilmo

28.68

61.42

11.2

2.8

—

Acute lymphocytic leukaemia, helper endpoint

28.68

61.42

11.2

2.8

—

Acute lymphocytic leukaemia

28.68

61.42

11.2

2.8

—

ILD, hospital admission 2, with pulmonary infections

135

280

4.95

61.14

5.2

3.4

—

Substance use, excluding alcohol

220

656

3.41

60.47

2.2

4.0

—

Hypothyroidism, levothyroxine purchases

170

202

4.79

60.47

3.9

1.8

—

Hypothyroidism and >3 levothyroxin purchases

170

202

4.79

60.47

3.9

1.8

—

Rheumatoid arthritis, including avohilmo

400

1646

2.46

60.43

3.1

3.7

—

Gastrointestinal diseases

459

929

2.49

60.02

4.0

2.9

—

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

298

1068

2.84

59.69

3.2

4.0

—

Other/unspecified seropositive rheumatoid arthritis

301

1089

2.81

59.22

3.2

4.0

—

Other systemic involvement of connective tissue

307

1122

2.78

59.22

3.2

3.9

—

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

143

204

5.06

58.93

4.9

3.7

—

Malignant neoplasm of respiratory system and intrathoracic organs

229

575

3.37

58.85

3.2

2.9

—

Seropositive rheumatoid arthritis, wide

303

1106

2.78

58.62

3.2

3.9

—

Infections of the skin and subcutaneous tissue

551

2602

2.12

58.23

4.1

3.5

—

Mental and behavioural disorders due to tobacco

135

294

4.73

57.77

2.3

4.3

—

Drug-induced cataract

9.46

57.74

5.0

4.0

—

Other viral diseases

298

1085

2.77

57.45

6.0

3.4

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

271

417

3.28

57.04

4.2

2.4

—

Glomerular disorders in diseases classified elsewhere

165

423

4.00

57.01

3.4

4.3

—

Intestinal infectious diseases

998

3223

1.78

56.85

3.8

3.5

—

Smoking dependency

135

298

4.67

56.83

2.3

4.3

—

Asthma (mode)

509

1198

2.29

56.77

3.2

2.9

—

Follow-up care involving plastic surgery

106

7.80

55.92

2.4

3.5

—

Diseases of the skin and subcutaneous tissue

843

2260

1.88

55.56

4.4

3.2

—

Mycoses

295

1098

2.73

54.98

4.7

3.8

—

Benzodiazepine use

866

3305

1.81

54.89

3.1

3.7

—

Other (seronegative) rheumatoid arthritis, wide

224

722

3.16

54.34

3.3

4.0

—

Missing teeth due to accident, extraction or parodontitis

567

2636

2.05

54.26

3.6

3.8

—

Malignant neoplasm of bronchus and lung, including Hilmo

224

589

3.23

54.09

2.9

3.0

—

Venous thromboembolism

528

2463

2.09

53.82

4.3

3.6

—

Chronic myeloproliferative disease

12.30

53.81

22.4

3.9

—

Other viral diseases

346

1395

2.49

53.63

5.7

3.4

—

Viral infections characterized by skin and mucous membrane lesions

412

1809

2.30

53.62

4.7

3.6

—

Heart failure, strict

592

2061

2.05

53.51

4.3

3.7

—

Persons encountering health services for examination and investigation

492

1091

2.27

53.14

4.1

3.4

—

Other soft tissue disorders, not elsewhere classified

797

2525

1.86

52.86

3.5

3.6

—

Later onset COPD, excluding more controls

208

482

3.38

52.83

3.1

3.4

—

Malignant neoplasm of bronchus and lung

200

493

3.42

52.72

2.9

3.0

—

Other necrotizing vasculopathies (FG)

102

189

5.59

52.69

3.0

4.3

—

Cellulitis

245

852

2.92

51.96

4.1

3.8

—

Crohn's disease NAS

106

207

5.28

51.63

2.9

4.3

—

Glomerular diseases

220

726

3.09

51.31

3.6

4.2

—

Unspecified urinary incontinence

128

295

4.46

51.05

3.0

4.1

—

Cytomegalovirus infection, IBD co-morbidity

9.16

50.93

10.2

3.9

—

Other and unspecified types of non-Hodgkin lymphoma, hilmo

158

6.05

50.58

6.7

4.5

—

Anaemia in chronic diseases classified elsewhere

8.54

50.50

3.6

3.8

—

Metabolic disorders

808

2726

1.82

50.40

3.6

3.7

—

Mantle cell lymphoma, including Hilmo

17.51

50.06

5.7

4.0

—

All-cause Heart Failure

576

2038

2.01

49.98

4.4

3.7

—

Other diseases of intestines

862

2761

1.78

49.77

3.6

3.5

—

Symptoms and signs involving the skin and subcutaneous tissue

617

3172

1.92

49.56

4.6

3.4

—

Certain disorders involving the immune mechanism

221

747

3.01

49.42

5.4

3.8

—

Diarrhoea and gastroenteritis of presumed infectious origin

854

3201

1.77

49.36

3.4

3.5

—

Diseases of the respiratory system

470

1055

2.24

49.33

4.2

3.0

—

ILD, hospital admissions 3, with pneumonia sepsis

121

275

4.52

49.13

5.4

3.4

—

Cytomegaloviral disease

8.66

48.84

10.2

3.6

—

Other problems related to primary support group, including family circumstances

145

368

3.91

48.49

4.4

3.3

—

Other functional intestinal disorders

439

1904

2.16

48.44

3.6

—

Non-invasive ventilation

223

678

2.97

47.76

4.1

3.7

—

Other/unspecified cytomegaloviral diseases

9.15

47.48

10.7

3.7

—

Chronic laryngitis and laryngotracheitis

173

520

3.39

47.18

2.7

4.1

—

Presence of other devices

258

971

2.68

46.72

3.8

3.5

—

Ulcerative colitis, NAS

159

456

3.55

46.62

3.5

4.4

—

Acute upper respiratory infections

866

3093

1.73

46.17

4.1

3.4

—

Codeine or tramadol medication

923

2969

1.71

45.59

3.6

3.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

343

901

2.42

45.46

3.9

3.2

—

Other necrotizing vasculopathies

118

281

4.34

45.26

3.2

4.2

—

Diseases of liver

344

1508

2.31

45.20

3.2

3.9

—

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

100

209

4.92

45.03

2.9

4.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

192

635

3.08

44.68

5.1

4.1

—

Disorders of lens

584

1892

1.94

44.62

4.3

3.7

—

Leukaemia of unspecified cell type

13.51

44.55

8.6

4.0

—

Examination and observation for other reasons

410

1072

2.23

44.05

3.5

—

Cardiovascular diseases (excluding rheumatic etc)

460

1253

2.12

44.00

4.0

3.0

—

COPD, hospital admissions 3, with asthma pneumonia sepsis

307

1097

2.42

43.57

3.4

4.0

—

Orthopaedic devices associated with adverse incidents

8.93

43.43

2.6

3.8

—

Other/unspecified rheumatoid arthritis

157

469

3.42

43.32

3.6

4.0

—

Ulcer of lower limb, not elsewhere classified

177

569

3.17

43.29

3.6

4.2

—

L01XE Protein kinase inhibitors

100

217

4.80

43.26

13.6

4.0

—

Headache

453

1773

2.05

42.83

3.6

3.0

—

Zoster [herpes zoster]

211

753

2.85

42.82

5.3

4.0

—

Kidney transplant status

203

4.91

42.81

4.3

4.4

—

Non-small cell lung cancer, including Hilmo

161

460

3.35

42.61

2.5

3.0

—

Adalimumab

117

289

4.13

42.60

2.4

4.1

—

Polyneuropathies and other disorders of the peripheral nervous system

245

951

2.62

42.19

5.0

3.9

—

COPD, hospital admission 2, with asthma infections

344

1315

2.27

42.19

3.3

4.0

—

Ulcerative colitis

240

923

2.63

42.01

3.4

4.2

—

Fungal Sepsis

119

6.29

42.00

6.0

4.6

—

Disorders of gallbladder, biliary tract and pancreas

820

3040

1.71

41.89

3.8

3.7

—

Other disorders of lacrimal gland

333

1488

2.26

41.85

4.2

3.7

—

Seronegative rheumatoid arthritis

132

360

3.74

41.79

3.1

4.2

—

Other reaction to severe stress, and adjustment disorders

298

1271

2.36

41.68

4.3

3.5

—

Factors influencing health status and contact with health services

229

389

2.97

41.56

4.9

3.0

—

Pain in limb

663

2468

1.81

41.48

3.6

—

Dermatitis

525

2771

1.90

41.40

4.1

3.5

—

Disorders of other endocrine glands

398

1886

2.09

41.14

3.8

3.6

—

Other specific joint derangements/joint disorders

576

1985

1.89

40.91

3.2

3.6

—

Depression medications

166

230

3.65

40.82

3.2

1.8

—

Pulmonary embolism

297

1278

2.35

40.81

4.5

3.8

—

Crohn disease (strict definition, require KELA)

199

4.80

40.76

2.9

4.4

—

Pulmonary heart disease, diseases of pulmonary circulation

321

1429

2.27

40.72

4.6

3.7

—

Unspecified kidney failure

136

386

3.60

40.67

4.7

3.6

—

Pulmonary heart disease

297

1281

2.35

40.60

4.5

3.8

—

Other acute lower respiratory infections

481

2377

1.94

40.18

4.5

3.5

—

Constipation

759

3076

1.72

40.17

3.3

3.8

—

Implicit fungal Sepsis

202

4.73

40.03

5.2

4.1

—

Heart failure and antihypertensive medication

246

611

2.66

39.83

4.8

4.1

—

Other noninfective gastroenteritis and colitis

248

994

2.52

39.83

4.0

4.1

—

Crohn disease (strict definition, require KELA, min 2 HDR)

199

4.75

39.80

2.8

4.4

—

Immunodeficiency with predominantly antibody defects

7.27

39.79

6.6

3.6

—

Dermatitis and eczema

900

3407

1.65

39.72

4.0

3.5

—

Marginal zone B-cell lymphoma, including Hilmo

13.49

39.53

6.7

3.8

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

133

380

3.58

39.42

9.3

3.7

—

Acute sinusitis

401

1816

2.06

39.30

4.9

3.3

—

Essential (haemorrhagic) thrombocythaemia

7.47

39.18

7.5

3.1

—

Acute bronchitis

382

1815

2.08

38.88

4.2

3.5

—

Other chronic obstructive pulmonary disease

436

1811

2.00

38.67

3.2

3.9

—

Hypertensive diseases (excluding secondary)

370

985

2.20

38.62

3.7

3.2

—

Sleep apnoea

761

2911

1.70

38.46

3.4

3.8

—

Other and unspecified dermatitis

447

2303

1.96

38.43

4.2

3.5

—

SLE (Finngen)

7.16

38.35

3.4

4.0

—

Gout

283

1067

2.36

38.35

4.2

4.1

—

All influenza (not pneumonia)

143

435

3.33

38.26

5.6

3.6

—

Disorders of lacrimal system

380

1849

2.07

38.15

4.0

3.6

—

Bleeding

710

2955

1.72

37.92

4.5

3.6

—

Crohn's disease of small intestine

203

4.59

37.89

2.5

4.5

—

Cardiovascular diseases

425

1106

2.08

37.85

3.9

3.0

—

COPD

446

1866

1.97

37.81

3.2

3.9

—

Other disorders of urethra and urinary system

584

2337

1.81

37.66

4.1

3.5

—

Other heart diseases

351

1052

2.19

37.63

4.2

3.2

—

Other dialysis

117

6.03

37.12

3.9

4.5

—

Dialysis

149

5.31

37.07

4.5

4.6

—

Symptoms and signs involving the digestive system and abdomen

809

2423

1.68

36.98

3.7

3.6

—

Pain in joint

479

1586

1.94

36.83

3.3

3.6

—

Other and unspecified polyneuropathies, also in other diseases

211

815

2.63

36.80

4.7

4.0

—

Cerebrovascular diseases (FINNGEN)

252

721

2.49

36.73

3.8

3.4

—

Undetermined asthma, excluding more controls

110

289

3.85

36.68

3.2

3.0

—

Acquired haemolytic anaemia

7.13

36.43

6.8

4.4

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

288

1286

2.26

36.33

3.9

—

Exposure to other specified factors

606

3196

1.75

36.15

3.7

3.5

—

Non-ischemic cardiomyopathy

327

1220

2.18

36.13

4.8

3.7

—

COPD, early/later onset

440

1924

1.95

36.06

3.2

3.9

—

Hypothyroidism, drug reimbursement

121

5.06

35.83

3.2

1.7

—

COPD, hospital admissions

436

1913

1.94

35.73

3.2

3.9

—

Other diseases of urinary system

811

2773

1.65

35.68

3.7

3.6

—

DVT of lower extremities

201

770

2.65

35.63

4.1

3.9

—

Asthma-related pneumonia or sepsis

357

1745

2.06

35.53

3.5

3.9

—

Asthma, hospital admissions 3, pneumonia

357

1745

2.06

35.53

3.5

3.9

—

Asthma-related pneumonia

356

1739

2.06

35.50

3.6

3.9

—

Other arthritis (FG)

265

1157

2.31

35.26

3.9

3.8

—

Ulcerative colitis (strict definition, require KELA)

163

563

2.93

35.18

3.5

3.8

—

Moderate visual impairment, binocular

113

5.92

35.01

2.9

3.9

—

Undetermined asthma

110

299

3.72

34.95

3.2

3.0

—

Disorders of mineral metabolism

110

301

3.74

34.81

3.9

4.1

—

Gout, FINNGEN

283

1278

2.23

34.56

4.2

4.0

—

Implicit fungal Sepsis

111

5.89

34.46

6.4

4.7

—

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

158

543

2.95

34.43

3.5

3.9

—

Crohn's disease of large intestine

151

5.04

34.37

3.4

4.0

—

Obesity due to excess calories

382

1942

1.98

34.23

2.9

3.7

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

171

616

2.81

34.16

3.4

3.9

—

Type of accident

269

1199

2.27

34.13

3.8

4.0

—

Non-small cell lung cancer

107

289

3.74

33.97

2.4

3.2

—

Disorders resulting from impaired renal tubular function

142

5.22

33.91

3.4

4.2

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

768

3012

1.64

33.89

4.1

3.6

—

Persons encountering health services in other circumstances, wide

934

3054

1.58

33.87

3.6

—

Other Crohn's disease

205

4.34

33.82

2.7

4.2

—

Viral infections characterized by skin and mucous membrane lesions

685

3534

1.67

33.73

4.4

3.4

—

Pneumonia due to other infectious organisms, not elsewhere classified

6.45

33.61

11.8

3.4

—

Disorders of calcium metabolism

228

4.15

33.53

3.6

4.2

—

Other heart diseases, wide

688

2504

1.69

33.53

4.0

3.5

—

Symptoms and signs concerning food and fluid intake

108

299

3.67

33.42

3.1

—

therapeutic use

108

5.91

33.29

2.6

4.0

—

Crohn disease (strict definition, all UC cases excluded)

152

4.94

33.12

2.8

3.9

—

Candidiasis

146

492

3.02

33.02

3.5

3.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

220

900

2.44

32.97

4.6

3.3

—

Other chronic obstructive pulmonary disease, including avohilmo

489

2240

1.82

32.55

3.2

3.9

—

Hypo-osmolality and hyponatraemia

186

716

2.62

32.30

3.6

4.2

—

Substance abuse, excluding more controls

462

2158

1.84

32.06

2.4

3.8

—

Senile cataract

510

1731

1.82

31.99

4.2

3.7

—

Localized swelling, mass and lump of skin and subcutaneous tissue

287

1349

2.15

31.95

4.4

3.6

—

COPD related to multimorbidity

381

1659

1.96

31.93

3.2

4.0

—

Other respiratory diseases principally affecting the interstitium

195

778

2.54

31.88

4.7

4.0

—

Systemic lupus erythematosus

102

5.89

31.80

3.4

—

Dental operations

510

1437

1.83

31.61

4.3

3.4

—

Disorders of eyelid, lacrimal system and orbit

688

3199

1.64

31.45

4.0

3.6

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

205

560

2.56

31.35

3.4

3.5

—

Pleural effusion

171

648

2.68

31.09

4.2

3.8

—

Hypothyroidism, strict autoimmune

513

1897

1.79

31.08

3.2

3.7

—

SLE, strict definition

101

5.85

31.02

3.5

3.4

—

SLE, ICD10

101

5.85

31.02

3.5

3.4

—

Use of hypnotics and sedatives

825

3008

1.58

30.74

3.6

—

Diseases of external ear

304

1486

2.06

30.54

3.1

3.9

—

Sleep apnoea, including avohilmo

764

2969

1.60

30.43

3.4

3.7

—

Haemolytic anaemias

121

5.32

30.42

6.5

4.1

—

Syncope and collapse

337

1455

2.00

30.11

3.6

3.3

—

Urticaria and erythema

302

1482

2.05

29.98

4.4

3.7

—

Neurological diseases, wide definition

207

402

2.60

29.86

3.7

3.0

—

Other viral diseases, not elsewhere classified

219

943

2.33

29.78

5.2

3.4

—

Symptoms and signs involving the circulatory and respiratory systems

743

2306

1.62

29.75

4.2

3.3

—

Convulsions, not elsewhere classified

178

695

2.55

29.47

3.6

3.1

—

Diagnoses used for exclusion with ILD

242

1100

2.22

29.39

4.3

4.0

—

Secondary malignant neoplasm of respiratory and digestive organs

10.84

29.12

1.4

3.6

—

Other pleural conditions

126

421

3.05

29.05

6.0

3.8

—

Other viral diseases, not elsewhere classified

174

686

2.56

28.97

5.7

3.7

—

Osteoporosis with pathological fracture (FG)

231

3.85

28.84

2.9

3.9

—

Immunodeficiencies

179

4.32

28.83

5.9

3.7

—

Gonarthrosis [arthrosis of knee](FG)

554

1880

1.72

28.79

3.4

3.9

—

Type 2 diabetes, wide definition

631

2457

1.65

28.73

3.7

3.9

—

Special screening examination for infectious and parasitic diseases

150

391

2.84

28.70

2.1

3.4

—

Heart failure and bmi 25plus

381

1360

1.91

28.50

4.2

3.5

—

Other autoimmune haemolytic anaemias

8.28

28.49

5.5

4.1

—

Fall on same level

869

3096

1.54

28.48

3.5

3.6

—

Respiratory insufficiency

201

4.03

28.42

3.4

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

103

309

3.40

28.39

5.5

3.4

—

Cough

338

1659

1.94

28.39

4.3

3.3

—

ILD, hospital admissions

166

652

2.59

28.14

4.9

3.9

—

Viral pneumonia (unknown virus, not influenza)

240

3.75

28.08

5.4

4.4

—

Pneumocystosis

6.83

28.06

12.4

3.6

—

Other specified/unspecified arthritis

225

1012

2.24

28.03

3.9

3.7

—

Visual impairment including blindness (binocular or monocular)

259

3.64

28.02

3.0

4.1

—

Other diseases of the respiratory system

209

913

2.32

27.99

3.9

4.1

—

Other respiratory disorders and diseases

209

913

2.32

27.99

3.9

4.1

—

Malignant neoplasm of eye, brain and central nervous system

5.81

27.80

3.9

3.4

—

Polymyalgia rheumatica

146

542

2.74

27.72

3.4

4.5

—

Interstitial lung disease

167

663

2.56

27.69

4.9

3.9

—

Interstitial lung disease endpoints

167

663

2.56

27.69

4.9

3.9

—

Candidiasis

242

1127

2.17

27.67

3.4

3.6

—

Zoster [herpes zoster]

413

2272

1.80

27.64

4.7

3.5

—

Other interstitial pulmonary diseases

167

664

2.55

27.61

4.9

3.9

—

Complications of internal orthopaedic prosthetic devices, implants and grafts

209

919

2.30

27.56

3.6

—

Other nutritional deficiencies

490

2704

1.72

27.51

2.9

3.6

—

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

128

4.89

27.47

5.6

3.1

—

Malignant neoplasm of digestive organs

275

1047

2.09

27.40

2.6

3.0

—

Asthma, hospital admission 2, infections

481

2756

1.72

27.36

3.3

3.6

—

Asthma-related infections

481

2756

1.72

27.36

3.3

3.6

—

Other diseases of blood and blood-forming organs

236

3.73

27.21

6.7

3.4

—

Diseases of the ear and mastoid process

851

2793

1.54

27.18

3.8

3.5

—

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

154

594

2.63

27.10

3.7

4.4

—

Hypertensive diseases

567

1911

1.68

27.00

3.8

3.7

—

Hypertension

566

1907

1.68

26.96

3.8

3.7

—

Hypokalaemia

129

456

2.87

26.87

3.3

4.6

—

Periodontitis

731

3141

1.56

26.82

3.6

—

Abdominal and pelvic pain

755

2423

1.57

26.71

3.6

—

Diverticular disease of intestine

546

2085

1.68

26.56

4.2

3.6

—

Acute pharyngitis

125

433

2.89

26.48

4.4

3.3

—

Polyarthrosis

183

713

2.41

26.46

2.7

3.9

—

Obesity

462

2602

1.72

26.46

2.7

3.6

—

Myalgia

196

854

2.32

26.38

2.9

3.7

—

Mantle cell lymphoma

24.47

26.33

5.9

4.0

—

Malignant neoplasm of breast, HER2-negative

258

794

2.14

26.29

2.4

2.8

—

COPD-related respiratory insufficiency

133

484

2.80

26.28

3.8

4.3

—

Obesity and other hyperalimentation

463

2611

1.72

26.26

2.7

3.6

—

Conductive and sensorineural hearing loss

631

2660

1.61

26.17

3.5

3.8

—

Paralytic ileus and intestinal obstruction

233

1093

2.15

26.15

3.6

3.8

—

Malignant neoplasm of other connective and soft tissue, including Hilmo

5.58

26.10

2.4

3.3

—

Chronic apical periodontitis

837

3154

1.52

26.04

3.5

3.6

—

Secondary malignant neoplasm of other and unspecified sites

8.88

25.97

2.2

3.9

—

Early onset COPD

206

924

2.26

25.94

3.2

4.0

—

Malignant neoplasm of breast

259

800

2.12

25.93

2.5

2.8

—

Hypertension, essential

544

1839

1.68

25.92

3.8

3.7

—

Polycystic ovarian syndrome, consortium definition

466

1584

1.75

25.90

3.3

3.2

—

Seropositive rheumatoid arthritis, strict definition

148

573

2.62

25.86

2.9

3.8

—

Chronic periodontitis, including avohilmo

725

3145

1.55

25.79

3.5

3.7

—

Soft tissue disorders

768

2561

1.55

25.78

3.6

—

Infliximab

8.13

25.73

2.3

3.2

—

Systemic lupus erythematosus, unspecified

5.64

25.71

3.3

3.6

—

Dermatitis due to substances taken internally

186

4.02

25.69

4.2

4.6

—

Pyogenic arthritis

204

3.85

25.61

2.9

4.5

—

Sensorineural hearing loss

607

2565

1.61

25.61

3.4

3.8

—

Other abnormal uterine and vaginal bleeding

195

597

2.36

25.54

3.5

3.2

—

Chronic gastritis

244

1177

2.09

25.52

4.5

3.8

—

Substance abuse

462

2558

1.71

25.51

2.4

3.9

—

Other skin changes

177

751

2.39

25.41

5.4

3.9

—

Malignant neoplasm of skin

337

1219

1.91

25.33

4.6

2.9

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

260

806

2.10

25.28

2.5

2.8

—

Malignant neoplasm of breast, including Hilmo

260

806

2.10

25.27

2.5

2.8

—

Generalized skin eruption due to drugs and medicaments

150

4.41

25.25

3.8

—

Phlebitis and thrombophlebitis (not including DVT)

202

912

2.24

25.04

3.5

3.7

—

Other disorders of ear

701

2967

1.55

25.00

3.6

3.7

—

Atrial fibrillation and flutter

227

672

2.21

24.89

3.4

3.5

—

Presence of other functional implants

463

1880

1.72

24.86

3.4

—

Other joint disorders

629

2073

1.61

24.74

3.2

3.6

—

Familial hypercholesterolemia

160

657

2.47

24.73

3.6

4.3

—

Mental and behavioural disorders due to psychoactive substance use

469

2595

1.68

24.61

2.5

3.9

—

Idiopathic thrombocytopenic purpura

105

5.14

24.60

6.3

3.8

—

Drug-induced osteoporosis with pathological fracture

6.90

24.58

3.3

3.5

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

834

3029

1.50

24.56

3.7

3.6

—

Mature T/NK-cell lymphomas, hilmo

7.33

24.52

8.4

3.8

—

COPD, hospital admissions 1, only main diagnosis

321

1466

1.89

24.52

3.2

3.9

—

L04AC Interleukin inhibitors

175

4.03

24.43

2.4

3.8

—

Exclusions for E4_PCOS_BROAD

160

660

2.45

24.42

4.3

3.9

—

Diseases of the digestive system

397

2268

1.75

24.36

3.9

3.7

—

Other and unspecified aplastic anaemias

8.96

24.30

5.9

3.9

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

480

2305

1.68

24.25

3.0

4.0

—

Arthropathies in other diseases classified elsewhere

110

4.96

24.24

4.1

4.0

—

Other diseases of anus and rectum

254

1266

2.02

24.15

4.2

3.7

—

Intestinal stricture

278

1436

1.95

24.04

3.4

4.0

—

Gout, unspecified

203

937

2.19

23.90

4.4

4.0

—

Urticaria

234

1140

2.07

23.84

4.9

3.7

—

ILD, hospital admissions 1, main diag only

146

585

2.54

23.84

4.9

4.1

—

FESS (DNB20)

116

414

2.84

23.78

3.7

4.1

—

Noninfectious colitis NAS

131

498

2.67

23.77

3.9

4.3

—

Mycoses

634

3566

1.55

23.70

4.0

3.5

—

Fibrosis and cirrhosis of liver

294

3.23

23.68

3.5

4.0

—

Ulcerative colitis (strict definition, all Crohn cases excluded)

125

465

2.72

23.65

3.7

3.9

—

Disorders of thyroid, IBD co-morbidities

118

286

2.92

23.44

3.6

3.3

—

Diseases of peritoneum

109

380

2.92

23.38

3.4

3.9

—

Acute generalized exanthematous pustulosis

168

4.04

23.34

3.9

—

Nonhereditary hypogammaglobulinemia

8.54

23.33

6.7

3.4

—

Cutaneous abscess, furuncle and carbuncle

210

991

2.14

23.31

3.7

3.8

—

Drug-induced osteoporosis

8.46

23.28

4.2

3.4

—

Misadventures to patients during surgical and medical care

132

511

2.62

23.11

3.6

—

Diseases of oral cavity, salivary glands and jaws

468

1417

1.71

23.09

4.1

3.5

—

Other cataract

349

1465

1.81

23.01

3.8

3.7

—

Viral pneumonia (known virus, not influenza)

100

5.10

22.95

6.6

3.8

—

Genitourinary diseases

424

1217

1.75

22.90

4.0

3.5

—

Protozoal diseases

112

4.83

22.85

11.8

3.9

—

Other diseases of the digestive system

286

1520

1.90

22.72

3.9

—

Vocal cord dysfunction

102

308

3.00

22.61

3.1

3.6

—

Malignant neoplasm of brain, including Hilmo

113

4.69

22.47

3.8

3.0

—

Unspecified haematuria

358

1680

1.78

22.45

4.1

3.8

—

Presence of cardiac and vascular implants and grafts

364

1532

1.78

22.35

3.0

3.5

—

Endocrine, nutritional and metabolic diseases

561

1768

1.61

22.30

3.5

3.6

—

Spondylopathies

600

2288

1.57

22.30

3.4

3.7

—

Malignant neoplasm of mesothelium and soft tissue

5.18

22.21

2.5

3.6

—

Diseases of the myoneural junction and muscle

126

487

2.63

22.19

3.5

4.2

—

Anxiety disorders, excluding more controls

584

2425

1.57

22.07

3.6

3.7

—

Valvular heart disease excluding rheumatic fever

380

1577

1.75

22.04

4.1

3.9

—

Hypercalcemia

162

4.01

22.00

4.1

4.0

—

Non-small cell lung cancer, adenocarcinoma

162

3.97

21.91

2.2

3.3

—

Collagenous colitis

329

3.00

21.89

3.9

4.2

—

Arthropathies

640

2092

1.56

21.88

3.4

3.6

—

Cholelithiasis, broad definition with cholecystitis

644

2839

1.53

21.84

3.8

3.6

—

Non-rheumatic valve diseases

376

1559

1.75

21.83

4.0

3.9

—

Malignant neoplasm of other connective and soft tissue

6.89

21.80

2.5

4.3

—

Diseases of the musculoskeletal system and connective tissue

380

1073

1.78

21.72

3.9

3.4

—

Neurotic, stress-related and somatoform disorders

620

2827

1.54

21.65

3.6

3.5

—

Malignant neoplasm of brain

5.87

21.56

4.3

3.8

—

Malignant neoplasm of breast, HER-positive

199

728

2.14

21.36

2.2

2.9

—

Neurological diseases

621

2011

1.56

21.30

3.7

3.6

—

Leisure time condition

157

684

2.32

21.29

3.5

4.2

—

Chronic ulcer of skin, not elsewhere classified

262

3.23

21.22

5.7

3.7

—

Hydronephrosis

108

395

2.77

21.20

2.8

3.7

—

Falls/tendency to fall

782

2655

1.48

21.18

3.5

3.6

—

Malignant neoplasm of breast, ER-positive, including Hilmo

201

733

2.13

21.11

2.3

2.8

—

Ethmoidectomy

116

441

2.66

21.11

3.7

4.0

—

Acute suppurative otitis media

184

797

2.17

21.06

3.7

3.2

—

Other antidepressants

755

2611

1.49

21.01

3.0

3.8

—

Exposure to unspecified factor

737

3612

1.47

20.96

3.1

3.7

—

Chronic periodontitis, complicated

424

2559

1.65

20.96

3.7

—

Cholangitis (primary sclerosing, PSC)

229

3.39

20.96

3.6

3.8

—

Amputation

113

426

2.70

20.94

3.2

4.3

—

Nerve, nerve root and plexus disorders

774

3245

1.47

20.85

3.5

3.6

—

Coxarthrosis [arthrosis of hip](FG)

398

1656

1.70

20.77

3.9

—

Other and unspecified drugs and medicaments

303

3.02

20.61

4.8

3.8

—

Mucosal proctocolitis

108

402

2.72

20.49

3.1

4.1

—

Hypoplasia of dental enamel

6.39

20.43

6.2

3.9

—

Insulin medication

479

2529

1.60

20.42

3.6

3.8

—

Impacted cerumen

109

410

2.70

20.33

2.7

4.1

—

Other and unspecified urticaria

162

730

2.24

20.29

4.3

4.0

—

GI-bleeding

279

1527

1.84

20.27

4.0

3.9

—

Other external causes of accidental injury

588

1897

1.56

20.26

3.9

3.6

—

Low back pain

543

2508

1.56

20.25

3.4

3.6

—

External causes of morbidity and mortality

446

1346

1.67

20.16

3.8

3.4

—

Mixed connective tissue disease

215

3.42

20.15

2.6

3.8

—

Gout, idiopatic and unspecified

230

1186

1.96

20.14

4.3

4.1

—

Haemorrhage from respiratory passages

287

1424

1.83

20.13

4.8

3.4

—

Follicular lymphoma, hilmo

159

3.88

20.12

4.8

4.4

—

Any operation in hilmo

20.64

20.10

2.8

1.2

—

Other specified/unspecified systemic involvement of connective tissue

187

3.60

20.02

2.8

3.8

—

Acute peritonitis

246

3.24

20.01

3.6

4.2

—

Stomatitis and related lesions

165

754

2.21

19.98

5.7

3.9

—

Anxiety disorders

621

2872

1.51

19.98

3.5

—

Bacterial pneumoniae

272

1299

1.86

19.95

3.7

3.3

—

Unspecified fall

401

2403

1.65

19.94

3.3

3.7

—

Any mental disorder

810

2804

1.45

19.92

3.3

3.7

—

Antihypertensive medication - note that there are other indications

391

1213

1.71

19.91

3.6

3.4

—

Convalescence

147

3.95

19.78

2.8

3.7

—

Retention of urine

292

1327

1.82

19.78

3.5

3.8

—

Cholelithiasis

612

2798

1.51

19.74

3.9

3.7

—

Accidents

585

1897

1.55

19.73

4.0

3.6

—

Obesity related asthma

274

1507

1.83

19.61

3.2

3.9

—

Disorders of parathyroid gland

179

843

2.12

19.44

3.8

3.7

—

Hyperkalaemia

221

3.33

19.32

4.3

4.6

—

Pain, not elsewhere classified

179

855

2.11

19.32

3.8

3.2

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

309

1176

1.79

19.28

4.4

2.9

—

Spondyloarthritis

139

600

2.34

19.27

2.6

4.2

—

Pain (limb, back, neck, head abdominally)

535

1710

1.57

19.25

3.9

3.6

—

Inflammatory diseases of female pelvic organs

381

1677

1.68

19.17

2.9

3.3

—

Sicca syndrome [Sjögren]

284

3.01

19.12

3.0

3.6

—

Psoriasis

224

1168

1.93

18.97

3.2

3.9

—

Cardiac arrhythmias

383

1487

1.68

18.96

3.6

3.4

—

Gastroduodenal ulcer

224

1165

1.93

18.95

3.2

3.8

—

Psoriasis vulgaris

157

720

2.20

18.88

3.4

4.0

—

Other disorders of kidney and ureter

125

521

2.43

18.85

4.9

4.2

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

177

847

2.09

18.81

2.8

3.6

—

Conjunctivitis (acute, non atopic)

222

1153

1.93

18.80

3.3

3.7

—

Diseases of arteries, arterioles and capillaries

522

2511

1.54

18.62

3.6

3.8

—

Chronic lower respiratory diseases

871

3300

1.41

18.59

3.2

3.7

—

Suppurative and unspecified otitis media

245

1165

1.87

18.59

3.6

3.3

—

Respiratory disorders in diseases classified elsewhere

6.73

18.58

4.3

3.2

—

Spondylopathies (FG)

106

411

2.60

18.57

2.3

4.0

—

Diseases of spleen

5.72

18.55

7.8

3.9

—

Small cell lung cancer, including Hilmo

6.37

18.55

1.8

3.6

—

Small cell lung cancer

6.37

18.55

1.8

3.6

—

Insulin, combination of fast acting with intermediate-acting or long-acting

479

2822

1.56

18.49

3.6

3.7

—

Other complications of surgical and medical care, not elsewhere classified

333

2.80

18.49

4.7

3.8

—

Volume depletion

100

379

2.68

18.40

3.0

4.4

—

Other or unspecified ileus, impaction or obstruction

161

754

2.15

18.36

3.5

4.1

—

Cystitis

614

2447

1.50

18.36

3.4

3.5

—

Gout, strict definition

171

821

2.11

18.34

4.5

3.9

—

Sarcoidosis

117

479

2.47

18.34

4.2

3.9

—

malignant neoplasm of male genital organs

209

635

2.02

18.20

3.7

3.0

—

Molar incisor enamel hypoplasia, with caries

6.99

18.11

7.6

3.0

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

291

1122

1.79

18.10

4.7

2.9

—

Diseases of middle ear and mastoid

394

1987

1.63

18.06

4.1

3.5

—

Exclusions for E4_PCOS_CONSORTIUM

472

1882

1.58

18.04

3.9

3.3

—

Hepatic failure, not elsewhere classified

140

3.89

17.89

4.2

4.5

—

Mood disorders, excluding more controls

653

2662

1.47

17.82

3.3

3.7

—

Pneumonia derived septicemia

127

4.05

17.81

4.2

4.0

—

Internal derangement of knee

258

1428

1.81

17.81

3.2

3.8

—

Pain in throat and chest

561

2232

1.51

17.78

4.0

3.3

—

MS-disease / Multiple Sclerosis

202

3.32

17.77

3.1

3.6

—

Episodal and paroxysmal disorders

789

2827

1.42

17.73

3.4

3.7

—

Gonarthrosis

456

1641

1.59

17.68

3.4

3.8

—

Psoriatic and enteropathic arthropathies

358

2.68

17.66

2.2

4.1

—

Type 2 diabetes

690

2786

1.45

17.64

3.4

3.7

—

Basal cell carcinoma

279

1083

1.79

17.56

4.6

2.9

—

Problems related to lifestyle

309

2.81

17.52

2.7

4.0

—

Other diseases of lip and oral mucosa

299

1745

1.72

17.52

4.1

3.7

—

Eosinophilic disease (BM)

7.63

17.50

5.4

3.1

—

Infections with a predominantly sexual mode of transmission

188

948

1.99

17.48

3.0

3.4

—

Poisoning by drugs, medicaments and biological substances

166

802

2.08

17.47

2.9

3.8

—

Epilepsy

248

1369

1.82

17.42

3.6

3.9

—

Speech therapy

1203

0.20

17.42

3.7

4.0

—

Decubitus ulcer and pressure area

241

3.09

17.39

3.9

4.0

—

Arthrosis

489

1727

1.56

17.37

3.5

3.7

—

Polyarteritis nodosa and related conditions

6.47

17.37

4.7

3.2

—

Basal cell carcinoma, including avohilmo

288

1128

1.77

17.32

4.6

2.9

—

Secondary thrombocytopenia

6.94

17.21

4.3

3.1

—

Anxiety (asthma-related co-morbidities)

385

1844

1.62

17.20

3.1

3.6

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

324

2.76

17.20

3.3

3.9

—

Pneumonia due to Streptococcus pneumoniae

117

4.10

17.16

3.4

3.2

—

327

1951

1.67

17.08

3.5

3.7

—

Disorders of optic nerve and visual pathways

325

2.75

17.06

4.2

4.0

—

Gastric ulcer

155

737

2.12

17.06

3.5

3.9

—

Benign neoplasms

689

2638

1.44

16.97

3.7

3.4

—

Hypothyroidism, other/unspecified

625

2826

1.46

16.83

3.5

3.6

—

Chronic myeloid leukaemia [CML], BCR/ABL-positive

7.42

16.77

10.9

3.6

—

Other and unspecified myopathies

346

2.67

16.71

4.0

3.8

—

Coxarthrosis

367

1484

1.64

16.70

3.9

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

645

2931

1.45

16.69

3.4

3.6

—

Other diseases of biliary tract

329

2.72

16.69

2.9

3.8

—

Sequelae of external causes of morbidity and mortality

206

1092

1.90

16.68

4.2

3.9

—

Visual disturbances and blindness

387

2443

1.59

16.65

3.8

3.5

—

Infection due to other mycobacteria

7.53

16.63

7.1

2.6

—

Inflammatory diseases of the central nervous system

296

2.81

16.62

4.1

4.2

—

STROKE

408

1749

1.59

16.58

3.7

—

malignant neoplasm of female genital organs

102

409

2.50

16.50

2.3

2.9

—

Serous carcinoma of ovary, including Hilmo

5.04

16.47

2.3

3.6

—

Disorders of choroid and retina

600

2931

1.46

16.43

3.9

3.8

—

Paracetamol or NSAID medication

125

258

2.45

16.40

4.3

3.8

—

Other diseases of liver

143

671

2.15

16.31

2.7

3.8

—

Haemorrhoids and perianal venous thrombosis

243

1362

1.79

16.30

3.4

3.7

—

Charcot foot

5.46

16.22

4.0

4.5

—

Pneumococcal septicemia

127

3.89

16.19

4.2

4.1

—

Injuries to the ankle and foot

473

2782

1.52

16.19

3.5

—

Dysphagia

197

1040

1.91

16.17

3.5

3.8

—

Diseases of the eye and adnexa

535

1781

1.51

16.14

4.2

3.2

—

Other follicular disorders

225

3.07

16.13

4.9

4.3

—

All anxiety disorders

388

1935

1.59

16.12

3.0

3.5

—

Malignant immunoproliferative diseases

6.25

15.97

9.5

4.1

—

Polyuria

182

940

1.95

15.97

4.1

3.9

—

Suppurative and necrotic conditions of lower respiratory tract

217

3.10

15.88

3.4

4.2

—

Sleep disorders (combined)

802

3036

1.39

15.88

3.4

3.7

—

Disorders of the thyroid gland

667

3058

1.42

15.82

3.6

—

Other female pelvic inflammatory diseases

120

533

2.27

15.69

3.7

3.6

—

Atrial fibrillation and flutter with reimbursement

177

561

2.02

15.69

3.9

3.7

—

Malignant neoplasm of prostate

199

616

1.95

15.66

3.5

3.0

—

Other diseases of upper respiratory tract

802

3022

1.39

15.65

3.9

3.6

—

Malignant neoplasm of ovary, including Hilmo

139

3.65

15.64

2.7

3.3

—

Malignant neoplasm of bladder, including Hilmo

379

2.52

15.56

3.8

3.0

—

Nonsuppurative otitis media

164

707

2.02

15.52

4.3

3.3

—

Caries of dentine, including avohilmo

589

2061

1.47

15.45

3.8

—

Shoulder lesions

527

2155

1.49

15.40

3.5

3.8

—

Insulin, intermediate and long-acting

412

2610

1.54

15.38

3.4

3.8

—

Other diseases of hard tissues of teeth

422

1395

1.57

15.35

3.7

3.5

—

Diabetes mellitus

705

2938

1.41

15.29

3.4

3.7

—

Giant cell arteritis

171

3.36

15.27

2.9

4.2

—

Coxibs

215

600

1.90

15.26

3.2

4.8

—

Wegener granulomatosis

5.84

15.22

3.1

4.0

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

294

1758

1.66

15.15

4.1

3.7

—

Osteomyelitis

250

2.89

15.14

3.4

3.9

—

Malignant neoplasm of colon, including Hilmo

126

579

2.19

15.13

2.7

3.0

—

Sequelae of cerebrovascular disease

295

1533

1.67

15.10

3.7

3.8

—

Rare circulating lymphoid malignancy

20.37

15.06

8.4

4.0

—

Type 2 diabetes, definitions combined

654

2710

1.42

15.04

3.3

3.8

—

Other infectious diseases

301

2.70

15.04

7.0

3.7

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

665

2839

1.42

15.04

3.2

3.8

—

Cerebrovascular diseases

555

2690

1.46

14.97

3.7

3.8

—

Spontaneous rupture of synovium and tendon

279

2.76

14.96

3.7

4.2

—

Other infectious diseases

354

2.55

14.95

7.3

3.6

—

Papulosquamous disorders

290

1757

1.66

14.86

3.3

3.8

—

Diseases of pulp and periapical tissues and dental caries

498

1703

1.50

14.86

4.1

3.7

—

Recurrent aphthous stomatitis , including avohilmo

121

553

2.21

14.81

6.2

3.8

—

Diabetes, varying definitions

700

2940

1.40

14.80

3.5

3.7

—

Pure hypercholesterolaemia

528

2354

1.47

14.78

3.5

3.8

—

Lung transplant status

7.09

14.72

11.3

4.2

—

Lung transplantation

7.09

14.72

11.3

4.2

—

Ulcerative enterocolitis

4.35

14.61

3.9

4.0

—

Type 2 diabetes, strict (exclude DM1)

656

2736

1.41

14.58

3.3

3.8

—

Juvenile arthritis (FINNGEN)

127

3.68

14.57

2.6

4.6

—

Aspergillosis

6.39

14.56

11.3

3.7

—

Irritable bowel syndrome

188

1013

1.87

14.52

3.6

3.5

—

Total colectomy

142

3.53

14.48

2.5

4.2

—

Total colectomy operation

142

3.53

14.48

2.5

4.2

—

Other CVD (FINNGEN)

294

2.50

14.47

3.8

3.4

—

Etanercept

197

3.09

14.47

3.5

3.7

—

Other retinal disorders

484

2559

1.48

14.46

3.8

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

571

2688

1.44

14.46

3.3

3.5

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

112

501

2.25

14.43

2.8

3.6

—

Lack of expected normal physiological development

6.12

14.30

2.1

1.6

—

Fibromyalgia

258

2.78

14.25

2.4

3.9

—

Hypopituitarism

264

2.77

14.24

4.0

4.7

—

Fracture of lumbar spine and pelvis

178

949

1.89

14.18

3.6

3.9

—

Bacterial pneumonia, not elsewhere classified

240

1226

1.73

14.18

3.7

3.3

—

Other disorders of patella

114

518

2.22

14.14

3.7

—

Disorders of synovium and tendon

353

1979

1.57

14.13

3.7

—

Ankylosing spondylitis

282

2.69

14.11

2.2

4.1

—

Malignant neoplasm of prostate, including Hilmo

197

626

1.88

14.11

3.8

3.0

—

Gonarthrosis,primary

644

2832

1.41

14.08

3.3

3.8

—

Heart failure and coronary heart disease

366

1663

1.57

14.08

4.0

3.7

—

Dental caries, including avohilmo

548

1930

1.46

14.06

4.1

3.7

—

Injuries to the knee and lower leg

829

3412

1.35

14.04

3.2

3.7

—

Chronic myeloid leukaemia, including Hilmo

12.17

14.04

10.9

3.5

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, including Hilmo

185

3.13

14.02

2.7

3.1

—

Peripheral artery disease

356

1816

1.57

14.02

3.6

3.9

—

Intracranial trauma

376

1706

1.55

13.99

3.8

3.5

—

Other otitis externa (chronic)

228

2.90

13.98

3.3

4.3

—

Bipolar affective disorders

123

579

2.14

13.97

2.8

3.6

—

Demyelinating diseases of the central nervous system

250

2.79

13.94

3.1

3.5

—

Otitis externa

167

880

1.91

13.87

3.4

4.0

—

Psoriasis (vulgaris), strict definition

104

3.94

13.85

2.3

4.2

—

Menorrhagia

223

689

1.81

13.83

3.0

—

ILD-related respiratory insufficiency

137

3.53

13.83

7.1

4.8

—

Diabetes, insulin treatment (Kela reimbursement)

702

3081

1.38

13.77

3.2

3.8

—

Non-selective monoamine reuptake inhibitors

273

1600

1.65

13.75

3.3

3.9

—

Asthma (diagnoses ohter than nonallergic)

609

3619

1.40

13.69

3.3

3.6

—

Poisoning by medicine

141

704

2.02

13.69

2.9

3.8

—

Other disorders of bone

139

691

2.03

13.67

3.5

3.9

—

Other condition

111

507

2.21

13.64

4.2

3.9

—

Temporal arteritis

148

3.40

13.64

2.9

4.3

—

Other ulcerative colitis

173

3.17

13.59

3.8

4.1

—

Ascites

265

2.72

13.59

3.3

4.4

—

Mood disorders

692

3259

1.38

13.59

3.2

3.6

—

Mood [affective] disorders

690

3255

1.38

13.56

3.2

3.6

—

Benign neoplasm: Colon

412

2640

1.50

13.47

3.9

3.8

—

Acquired absence of limb

10.28

13.45

3.2

4.7

—

Acute pancreatitis

155

806

1.94

13.42

4.3

4.1

—

Amputation of toe

290

2.63

13.42

3.0

4.2

—

Injury, poisoning and certain other consequences of external causes

360

1146

1.58

13.42

4.0

3.3

—

Other specified/unspecified bacterial intestinal infections

228

2.85

13.39

3.4

4.2

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

668

3310

1.38

13.37

3.5

3.6

—

Dorsalgia

668

2583

1.39

13.33

3.3

3.6

—

Acute posthaemorrhagic anaemia

107

3.82

13.31

7.0

4.2

—

Special screening examination for neoplasms

145

3.35

13.28

2.2

4.1

—

Intestinal adhesions without obstruction

303

2.57

13.27

3.2

3.7

—

Cystic kidney disease

112

3.75

13.26

4.5

3.8

—

Depression

633

3094

1.39

13.26

3.2

3.6

—

Insulin, fast-acting

262

1595

1.65

13.21

3.4

3.8

—

Benign neoplasm of colon, rectum, anus and anal canal

473

2837

1.45

13.18

3.8

—

Injuries to the head

773

3533

1.35

13.17

3.5

3.6

—

Drug-induced polyneuropathy

5.96

13.10

7.9

3.5

—

Infectious mononucleosis

214

2.88

13.09

5.1

3.6

—

Other local infections of skin and subcutaneous tissue

371

2.40

13.09

3.7

4.0

—

Malignant neoplasm of bladder

199

2.95

12.96

2.9

3.2

—

Hyperparathyroidism

144

731

1.96

12.94

3.8

3.6

—

Impingement syndrome of shoulder

181

1002

1.82

12.91

3.5

3.9

—

Later onset COPD

239

1130

1.70

12.89

3.1

4.0

—

Giant cell arteritis with polymyalgia rheumatica

154

3.26

12.82

2.9

4.2

—

Other gastritis (incl. Duodenitis)

170

926

1.85

12.78

3.1

3.8

—

Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care

280

2.61

12.74

3.6

4.1

—

Disorders of lipoprotein metabolism and other lipidaemias

559

2457

1.41

12.71

3.5

3.8

—

Type 2 diabetes, definitions combined, including avohilmo

643

2717

1.38

12.68

3.3

3.8

—

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

177

978

1.82

12.68

2.8

3.5

—

Endocarditis

130

3.46

12.67

2.7

3.9

—

Suicide or other Intentional self-harm

159

851

1.88

12.62

2.8

3.7

—

Malignant neoplasm of ovary

102

3.78

12.57

2.7

3.7

—

Cirrhosis of liver, NAS

226

2.80

12.50

3.8

4.4

—

Other anxiety disorders

274

1476

1.61

12.47

2.8

3.5

—

Other juvenile arthritis

112

3.63

12.46

2.8

4.6

—

Atherosclerosis, excluding cerebral and coronary sclerosis

329

1687

1.55

12.43

3.5

3.9

—

Other and unspecified local infections of skin and subcutaneous tissue

350

2.40

12.36

3.6

4.0

—

Hodgkin lymphoma, hilmo

104

3.75

12.29

4.6

3.4

—

Peripheral artery operations in Hilmo

115

557

2.08

12.21

2.9

4.0

—

Excessive, frequent and irregular menstruation

236

760

1.71

12.21

3.3

2.9

—

Other diseases of pericardium

169

3.08

12.20

6.9

3.4

—

Non-small cell lung cancer, squamous

114

3.56

12.13

2.6

3.2

—

Bacterial pneumonia (organism specified)

330

1960

1.53

12.09

5.1

3.6

—

Depression or dysthymia

476

1821

1.45

12.08

3.2

4.0

—

Acute pancreatitis (for exclusion)

155

836

1.87

12.07

4.3

3.8

—

Other predominantly sexually transmitted diseases, not elsewhere classified

120

593

2.04

12.05

2.9

3.3

—

Ankylosing spondylitis, ICD10

294

2.51

12.02

2.2

4.1

—

Spinal stenosis

378

1926

1.50

12.02

3.8

—

Cholangitis (primary sclerosing, PSC), with reimbursement 202

4.66

11.98

3.1

3.7

—

Other intervertebral disc disorders

557

2402

1.40

11.98

3.3

3.6

—

Alcoholic liver disease

374

2.33

11.97

2.5

4.2

—

Spirochaetal infections, other/unspecified

319

2.45

11.96

4.6

4.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

144

761

1.91

11.93

3.4

4.3

—

Injuries to the thorax

324

2126

1.53

11.92

3.6

3.8

—

Dizziness and giddiness

520

2945

1.40

11.90

3.5

3.7

—

Other predominantly sexually transmitted diseases, not elsewhere classified

104

490

2.14

11.87

3.1

3.3

—

Focal epilepsy, strict definition

152

819

1.87

11.86

3.3

4.3

—

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

284

2.53

11.85

3.6

3.2

—

Cystic kidney disease

121

3.46

11.85

4.5

3.7

—

Colorectal cancer

140

719

1.92

11.77

2.7

2.9

—

Fracture of lower leg, including ankle

373

2502

1.48

11.74

3.1

3.7

—

Pain associated with micturition

415

2.24

11.74

3.1

3.8

—

Weight loss

409

2.25

11.74

3.3

4.0

—

Psoriatic arthropathies

322

2.42

11.69

2.1

4.1

—

Abnormalities of heart beat

239

1439

1.64

11.69

3.2

3.4

—

Malignant neoplasm of urinary organs

269

2.55

11.63

3.7

3.2

—

Rheumatism, unspecified

101

475

2.14

11.61

3.1

3.9

—

Spondylopathies in diseases classified elsewhere

5.23

11.60

4.2

2.9

—

Psychiatric diseases

693

2576

1.35

11.57

3.5

3.8

—

Disorders of skin appendages

311

2035

1.53

11.56

4.2

3.6

—

Juvenile rheumatoid arthirtis

5.11

11.51

3.0

5.4

—

Hard cardiovascular diseases

583

2530

1.38

11.42

3.7

—

Disorders of sclera, cornea, iris and ciliary body

364

2471

1.48

11.41

3.6

—

Viral hepatitis, IBD co-morbidity

100

3.63

11.33

2.9

3.6

—

Abnormal results of function studies

279

2.50

11.29

4.9

3.9

—

Abscess of lung

4.73

11.28

3.6

3.8

—

Haemorrhage, not elsewhere classified

130

3.29

11.27

4.3

3.6

—

Colectomy operation

137

728

1.90

11.22

2.9

4.3

—

Arthropathic psoriasis

391

2.25

11.22

2.1

4.3

—

Hypertensive heart and/or renal disease

208

920

1.70

11.22

3.4

4.0

—

Fracture of rib(s), sternum and thoracic spine

223

1363

1.65

11.21

3.7

4.0

—

Other disorders involving the immune mechanism, not elsewhere classified

116

3.44

11.16

8.4

3.9

—

Insulin, fast-acting or short human

264

1681

1.58

11.16

3.4

3.9

—

Focal epilepsy

159

887

1.80

11.12

3.4

4.2

—

Infections with a predominantly sexual mode of transmission

216

1218

1.66

11.11

2.9

3.3

—

Sequelae with surgical and medical care as external cause

156

867

1.81

11.08

4.3

4.2

—

Seborrhoeic dermatitis

350

2.31

11.01

4.4

4.0

—

Malignant melanoma

420

2.18

10.99

4.8

3.0

—

Other inflammatory liver diseases

219

2.68

10.94

2.8

3.9

—

Oesophageal varices

164

2.99

10.94

6.1

4.3

—

Hyperlipidaemia, other/unspecified

289

1735

1.54

10.90

3.6

3.8

—

Adrenocortical insufficiency

123

3.32

10.86

3.7

4.1

—

Eosinophilia

4.56

10.83

5.2

3.5

—

Malignant neoplasm, without specification of site, including Hilmo

123

3.30

10.81

4.2

3.6

—

Malignant melanoma, including Hilmo

107

529

2.04

10.80

4.5

3.0

—

Selective serotonin reuptake inhibitors

675

2640

1.34

10.73

3.1

3.8

—

Allergic urticaria

274

2.47

10.73

5.6

4.0

—

Cholecystitis

111

558

2.01

10.71

3.5

4.2

—

Acute and subacute iridocyclitis

134

718

1.88

10.71

3.7

4.0

—

Pruritus

381

2.23

10.62

3.7

—

Iridocyclitis

159

901

1.78

10.59

3.4

4.0

—

Hypocalcemia

3.89

10.56

2.8

4.5

—

Use of interferon beta-1a

4.89

10.53

3.3

3.6

—

Gingivitis and periodontal diseases

716

2800

1.32

10.50

3.9

3.5

—

Other dorsopathies, not elsewhere classified

662

2597

1.34

10.50

3.4

3.6

—

Malignant neoplasm of colon

435

2.13

10.47

2.4

3.0

—

Use of pramipexole

165

949

1.75

10.45

3.3

4.1

—

Marginal zone B-cell lymphoma

11.14

10.42

6.4

5.2

—

Malignant neoplasm of kidney, except renal pelvis

248

2.53

10.41

3.6

3.4

—

Chronic pancreatitis

457

2.10

10.37

2.1

4.2

—

Non-small cell lung cancer, adenocarcinoma, helper endpoint

255

2.51

10.36

2.2

4.3

—

Other specified/unspecified necrotizing vasculopathies

5.07

10.35

3.2

3.7

—

Other CVD

154

871

1.78

10.34

3.7

4.2

—

Deforming dorsopathies

199

1208

1.66

10.31

3.2

3.8

—

Diabetes medication

686

3085

1.32

10.29

3.2

3.7

—

Mental and behavioural disorders due to opioids

3.69

10.27

2.4

3.1

—

Diseases of pulp and periapical tissues, including avohilmo

728

2875

1.31

10.26

3.7

3.6

—

Postmenopausal osteoporosis with pathological fracture

215

2.64

10.26

2.8

3.9

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

339

2252

1.47

10.25

3.7

3.6

—

Concussion

310

1691

1.50

10.23

3.5

—

Other arthrosis

336

1574

1.48

10.20

3.0

3.8

—

Other (not insulin) diabetes medications

645

2881

1.33

10.19

2.9

3.8

—

Acetic acid derivatives and related substances

194

589

1.72

10.18

3.9

4.7

—

Diaphragmatic hernia

265

1729

1.54

10.14

4.3

3.7

—

Injuries to the hip and thigh

339

2101

1.47

10.13

3.8

3.7

—

Acidosis

3.86

10.12

2.0

5.2

—

Amyloidosis

3.85

10.11

3.0

4.7

—

Corticotropin deficiency

8.09

10.09

2.4

4.2

—

Alcohol use disorder, Swedish definition

375

2400

1.44

10.09

2.5

3.9

—

Anterior Iridocyclitis

140

776

1.82

10.07

3.6

4.1

—

Malignant neoplasm of head and neck

223

2.58

10.02

3.5

3.3

—

Artificial joint operation, meniscal resection

626

3063

1.33

10.00

3.3

3.8

—

Thyroiditis, ILD-related definition

346

2.24

9.98

3.0

3.8

—

Lower back pain or/and sciatica

697

3485

1.31

9.95

3.4

3.6

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma, including Hilmo

10.11

9.93

10.2

4.1

—

Recurrent or chronic depression

239

1062

1.59

9.93

2.5

3.9

—

Viral warts

328

2.28

9.92

3.5

4.1

—

Vaginitis/vulvovaginitis/vulvitis/abscess of vulva

478

2.04

9.91

2.5

3.3

—

Otitis media, unspecified

365

2.16

9.90

3.9

3.3

—

Diabetic nephropathy, excluding more controls

115

490

1.95

9.90

3.5

3.4

—

Other disorders of optic [2nd] nerve and visual pathways

231

2.55

9.87

4.6

4.5

—

Other disorders of veins

261

1698

1.53

9.85

3.4

3.5

—

Malignant melanoma of skin, including Hilmo

420

2.11

9.81

4.3

3.2

—

Abnormal findings on diagnostic imaging of other body structures

467

2.05

9.80

4.2

3.8

—

Dermatophytosis

102

515

2.00

9.78

4.9

4.0

—

Molar incisor enamel hypoplasia

152

2.91

9.75

5.8

3.3

—

Osteonecrosis

215

2.59

9.73

5.6

4.5

—

Open wound of head

384

2622

1.42

9.62

3.6

3.8

—

Other diseases of intestine

106

547

1.95

9.55

3.2

4.1

—

Unspecified acute lower respiratory infection

107

554

1.95

9.54

5.5

4.2

—

Malignant neoplasm, without specification of site

3.84

9.53

4.7

3.2

—

Vertigo of central origin

4.24

9.52

7.4

4.3

—

Other symptoms and signs involving the circulatory and respiratory systems

241

2.48

9.52

4.6

3.6

—

Ankylosing spondylitis, strict definition

123

3.13

9.51

2.7

3.6

—

Hypotension

134

747

1.81

9.50

3.9

4.3

—

Brain meningioma, including Hilmo

118

3.18

9.48

3.3

3.8

—

Assault by bodily force

206

2.60

9.47

2.5

3.9

—

Chronic tubulo-interstitial nephritis

108

3.29

9.47

4.5

4.0

—

Hepatomegaly and splenomegaly, not elsewhere classified

7.24

9.46

5.6

4.0

—

Asthma/COPD (KELA code 203)

630

3292

1.31

9.41

3.2

3.7

—

Herpesviral [herpes simplex] infections

408

2.10

9.37

4.6

3.8

—

Conduction disorders

217

1110

1.59

9.36

3.8

3.7

—

Abnormal findings on examination of blood, without diagnosis

343

2196

1.44

9.35

4.5

3.8

—

Allergic asthma (mode), excluding more controls

102

512

1.96

9.29

2.5

2.7

—

Hyperplasia of prostate

263

972

1.54

9.27

4.4

4.1

—

Pain and other conditions associated with female genital organs and menstrual cycle

117

577

1.87

9.23

3.2

2.9

—

Familial hypercholesterolemia, with ischemic heart disease

438

2.06

9.22

2.9

4.0

—

Osteonecrosis due to drugs

4.42

9.22

4.7

3.9

—

Other and unspecified tonsillitis

175

884

1.67

9.21

2.8

3.1

—

Soft tissue disorders related to use, overuse and pressure

182

1114

1.64

9.19

3.7

—

Hernia

619

3165

1.31

9.17

3.9

3.6

—

Ulcerative proctitis

175

2.72

9.16

4.6

3.7

—

Glomerulonephritis

379

2.13

9.15

4.3

4.2

—

Malignant melanoma of skin

314

2.25

9.15

4.6

3.2

—

Abnormal weight loss

373

2.14

9.12

3.0

4.1

—

Fissure and fistula of anal and rectal regions

158

934

1.70

9.12

4.6

3.7

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

111

3.22

9.10

9.1

3.7

—

Sacroiliitis, not elsewhere classified

121

3.09

9.10

2.1

3.4

—

Abscess of anal and rectal regions

259

2.38

9.06

2.7

4.1

—

Other overlap syndromes

4.18

9.05

2.4

4.3

—

Open wound of lower leg

107

565

1.91

9.03

3.2

4.1

—

Carpal tunnel syndrome

391

2473

1.40

9.02

3.4

3.6

—

Hypoparathyroidism

122

3.09

9.01

3.6

3.7

—

Other/unspecified dorsalgia

245

1600

1.52

9.01

3.1

3.6

—

Pneumothorax

260

2.37

9.00

3.6

3.5

—

Microscopic polyangiitis

9.27

9.00

2.9

3.6

—

Other and unspecified immunodeficiencies with predominantly antibody defects

4.48

8.96

7.1

3.3

—

Other disorders of adrenal gland

166

2.75

8.96

3.5

3.9

—

Primary biliary cholangitis (PBC)

4.40

8.91

3.1

3.0

—

Malignant neoplasm of bone and articular cartilage

8.97

8.91

2.7

3.8

—

Malignant neoplasm of other and unspecified parts of biliary tract, including Hilmo

4.97

8.87

2.3

4.1

—

Primary gonarthrosis, bilateral

362

2202

1.41

8.86

3.2

3.9

—

Diseases of tongue

184

2.64

8.85

4.2

3.5

—

Small cell lung cancer, helper endpoint

3.41

8.81

1.8

4.1

—

Hidradenitis suppurativa

103

3.25

8.79

2.3

3.4

—

403

2572

1.38

8.78

2.5

3.9

—

Allergic asthma (mode)

102

523

1.92

8.76

2.5

2.7

—

Other disorders of nervous system

245

2.40

8.75

5.1

4.2

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites, including Hilmo

7.88

8.73

4.6

5.6

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

218

1404

1.55

8.72

3.1

3.6

—

Amyloidosis, other/unspecified

3.82

8.69

2.5

4.9

—

Dyshidrosis [pompholyx]

4.87

8.64

4.5

4.9

—

Malignant neoplasm of oral cavity

3.77

8.63

4.0

3.0

—

Viral and other specified intestinal infections

162

943

1.66

8.62

3.7

3.5

—

Ventral hernia

173

1065

1.63

8.59

3.4

3.9

—

Obsessive-compulsive disorder

164

2.71

8.57

3.4

—

Renal tubulo-interstitial disorders in diseases classified elsewhere

7.66

8.56

3.5

3.6

—

Viral and other specified intestinal infections

130

723

1.76

8.56

3.8

3.6

—

Peripheral arterial reconstruction

134

772

1.75

8.55

3.1

4.1

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

222

1450

1.54

8.54

4.4

3.6

—

Optic neuritis

126

2.98

8.53

3.9

3.4

—

In situ neoplasms

258

1742

1.49

8.48

5.0

3.5

—

Carrier of infectious disease

3.63

8.45

4.1

3.7

—

Atypical mycobacterium lung infection

5.03

8.43

7.9

3.9

—

Open wound of forearm

345

2.14

8.43

4.6

4.2

—

Hernia of abdominal wall

308

2155

1.43

8.41

3.4

3.9

—

Other shoulder lesions

287

2.25

8.41

3.1

4.3

—

Herpesviral [herpes simplex] infections

146

865

1.70

8.40

3.8

3.6

—

Disorders of vestibular function (Vertigo)

317

2192

1.43

8.40

3.7

—

Assault

379

2.07

8.36

2.7

3.8

—

Amputation of thigh

117

3.05

8.35

3.5

4.8

—

Panhypopituitarism

3.91

8.31

3.1

4.3

—

Diseases of inner ear

363

2531

1.39

8.30

3.7

—

Chondropathies

100

532

1.89

8.29

2.9

4.0

—

Lung diseases due to external agents

113

626

1.82

8.25

4.1

4.0

—

Malignant neoplasm of oral cavity, including Hilmo

102

3.18

8.24

4.5

3.1

—

Hypersplenism

10.91

8.23

7.1

3.5

—

Abnormality of white blood cells, not elsewhere classified

4.97

8.22

10.1

3.3

—

Other noninfective disorders of lymphatic vessels and lymph nodes

113

3.06

8.19

2.0

3.7

—

Personality disorders, excluding more controls

132

766

1.73

8.18

2.6

3.7

—

Stroke, excluding SAH

430

2317

1.36

8.18

3.8

—

Brain meningioma

113

3.04

8.17

3.3

3.8

—

Perforation of tympanic membrane

363

2.09

8.16

3.9

3.8

—

Hypertensive Heart Disease

177

862

1.62

8.15

3.2

4.0

—

Injuries to the shoulder and upper arm

559

3463

1.30

8.11

3.4

3.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

116

630

1.80

8.10

3.9

4.1

—

Fracture of foot, except ankle

154

935

1.66

8.10

3.2

3.7

—

Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder

136

2.83

8.03

2.6

3.1

—

Schizophrenia or delusion, excluding more controls

174

1080

1.60

8.01

3.0

4.0

—

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

385

2.03

7.98

6.4

3.1

—

Disorders of conjunctiva

519

3179

1.31

7.97

3.9

3.4

—

Hallux valgus (acquired)

201

928

1.56

7.96

3.8

3.7

—

Car occupant injured in other and unspecified transport accidents

116

655

1.78

7.95

3.8

3.7

—

Tobacco use

177

2.58

7.93

3.4

3.8

—

Hypoplasia of dental enamel , including avohilmo

144

2.75

7.89

6.3

3.4

—

225

1302

1.51

7.89

3.8

3.9

—

Other noninflammatory disorders of vagina

251

2.29

7.85

2.4

3.3

—

Gingival hyperplasia

161

2.66

7.83

3.6

4.7

—

Other embolism and thrombosis

479

1.91

7.82

4.5

3.9

—

Conjunctivitis

461

2900

1.33

7.81

3.8

3.5

—

Cervical disc disorders

238

1610

1.48

7.79

4.6

3.6

—

Sequelae of injuries, of poisoning and of other consequences of external causes

150

915

1.65

7.77

3.8

4.1

—

Other abnormalities of plasma proteins

3.97

7.77

4.0

3.5

—

Congenital malformations, deformations and chromosomal abnormalities

349

2408

1.38

7.75

3.5

—

Chronic sinusitis

255

1749

1.46

7.74

3.7

3.5

—

Polycystic kidney disease

3.19

7.73

3.5

3.9

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

120

669

1.75

7.73

3.8

4.0

—

Bronchitis, not specified as acute or chronic

285

2.19

7.71

4.6

4.5

—

Benign neoplasm: Colon, unspecified

185

1190

1.56

7.70

3.9

4.0

—

Visual disturbances

316

2259

1.40

7.69

4.0

3.6

—

Monocytic leukaemia

8.60

7.68

19.1

5.0

—

Other specific arthropathies, wide

3.78

7.67

2.7

4.2

—

Congenital malformations of the urinary system

229

2.34

7.66

4.4

4.7

—

162

949

1.61

7.65

3.7

4.0

—

Faecal incontinence

319

2.12

7.63

4.2

4.1

—

Colonic or urogenital fistula

176

1122

1.58

7.61

4.5

3.9

—

Amputation of foot

3.16

7.61

3.7

4.9

—

Rotator cuff syndrome

386

2033

1.37

7.61

3.1

3.8

—

Psoriatic arthropathies, ICD10

373

2.03

7.61

2.2

4.1

—

Transport accidents

266

1583

1.45

7.59

3.3

3.7

—

Anomalies of dental arch relationship, including avohilmo

124

650

1.73

7.57

3.8

3.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

154

511

1.67

7.57

3.4

5.0

—

Generalized anxiety disorder

456

1.92

7.57

2.7

3.4

—

Other neurological diseases

492

2951

1.31

7.56

3.7

—

Phobic anxiety disorders

367

2.02

7.51

2.8

3.5

—

Personal history of malignant neoplasm

206

2.40

7.51

5.4

3.3

—

Hepatocellular carcinoma, including Hilmo

3.71

7.49

2.4

3.3

—

Other encephalitis

3.12

7.48

3.6

3.9

—

Other diseases of pancreas

283

2.18

7.44

3.8

—

379

2530

1.36

7.44

2.5

3.9

—

Reactive arthropathies

277

2.18

7.40

4.0

4.3

—

Sodium-glucose co-transporter 2 (SGLT2) inhibitors

187

1217

1.54

7.40

2.4

4.0

—

Glucagon-like peptide-1 (GLP-1) analogues

187

1217

1.54

7.40

2.4

4.0

—

Encephalitis

104

3.04

7.39

3.6

3.8

—

Otitis externa, unspecified

378

2.00

7.34

3.3

4.1

—

Disorders of continuity of bone

331

2.07

7.33

4.4

4.1

—

Crystal arthropathies, rheuma endpoint

3.47

7.31

4.8

—

Pyothorax

167

2.55

7.29

3.8

4.5

—

Sequelae of other external causes

191

2.44

7.27

3.8

4.0

—

Diseases of male genital organs

346

1256

1.39

7.26

4.1

—

Malignant neoplasm of stomach, including Hilmo

167

2.54

7.25

2.5

3.0

—

Elevated blood glucose level

313

2.10

7.22

4.6

3.9

—

Other psoriatic arthropathies

360

2.02

7.22

2.2

4.0

—

Folate deficiency anaemia

5.85

7.17

5.3

4.6

—

Malignant neoplasm of other and unspecified parts of biliary tract

6.71

7.16

2.4

3.9

—

Ulcerative rectosigmoiditis

255

2.21

7.16

4.4

—

Congenital malformations, deformations and chromosomal abnormalities

378

2589

1.35

7.15

3.6

3.5

—

Atopic dermatitis, strict definition with reimbursement

165

1016

1.57

7.10

3.1

3.3

—

Dorsopathies

653

2626

1.27

7.08

3.6

—

Stroke, including SAH

440

2419

1.32

7.08

3.7

3.8

—

Congenital malformations of the urinary system

244

2.24

7.06

4.3

4.6

—

Myocarditis

112

2.88

7.05

4.0

3.6

—

Squamous cell neoplasms and carcinomas of the skin

250

2.22

7.05

7.1

3.1

—

UC patients in KELA-register (code 208), prior to 1994

158

2.57

7.04

3.9

4.1

—

Myocardial infarction, without ST-elevation

291

1897

1.40

7.02

3.5

4.0

—

Malignant neoplasm of stomach

135

2.69

7.00

2.3

3.2

—

Diseases of salivary glands

200

1338

1.50

6.98

3.0

3.8

—

3.06

6.98

4.5

4.9

—

Other/unspecified synovitis and tenosynovitis

379

1.97

6.94

4.7

4.1

—

Explicit fungal Sepsis

7.05

6.94

2.4

4.3

—

Chronic diseases of tonsils and adenoids

475

2299

1.31

6.93

3.4

3.6

—

Listeriosis

9.92

6.91

16.9

2.9

—

Malignant neoplasm of bone and articular cartilage of limbs, including Hilmo

8.51

6.89

2.0

4.8

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

285

2033

1.40

6.88

2.5

4.0

—

Corns and callosities

234

2.25

6.87

3.3

4.1

—

Degeneration of macula and posterior pole

341

1994

1.37

6.86

3.6

3.8

—

Idiopathic gout

388

1.95

6.86

4.3

4.4

—

Pneumonitis due to solids and liquids

333

2.03

6.86

2.4

4.5

—

Extreme obesity with alveolar hypoventilation

137

2.67

6.83

2.3

4.6

—

Chorioretinal inflammation

3.06

6.80

3.4

3.7

—

Other diseases of stomach and duodenum

216

2.29

6.79

3.6

—

Neuralgia and neuritis, unspecified

149

2.58

6.78

3.8

4.2

—

Bronchiectasis

308

2.07

6.76

3.6

4.5

—

Fracture of femur

188

1131

1.51

6.76

3.7

4.0

—

Meniscus derangement

331

1629

1.37

6.73

3.7

3.8

—

Biguanides

607

2934

1.26

6.71

2.8

3.8

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

10.91

6.70

8.6

5.9

—

Hypertensive Renal Disease

127

2.71

6.69

4.2

3.6

—

Palindromic rheumatism

5.66

6.69

2.3

5.5

—

Calcific aortic valvular stenosis, diagnosis (helper)

216

1436

1.47

6.66

4.3

3.8

—

Operations 2 for CAVS

216

1436

1.47

6.66

4.3

3.8

—

Panic disorder

413

1.90

6.64

2.5

3.7

—

Other crystal arthropathies

3.24

6.62

4.8

3.7

—

Emotionally unstable personality disorder

351

1.98

6.61

2.5

3.5

—

Inflammatory disease of cervix uteri

175

2.42

6.61

2.9

3.7

—

Malignant neoplasm of adrenal gland, including Hilmo

10.41

6.60

4.0

—

Disorders of oesophagus in diseases classified elsewhere

3.40

6.59

4.3

3.9

—

Calcific aortic valvular stenosis, including rheumatic fever

216

1438

1.46

6.58

4.3

3.8

—

Colorectal adenocarcinoma

105

609

1.73

6.58

2.8

3.1

—

Calcific aortic valvular stenosis

216

1440

1.46

6.57

4.3

3.8

—

Calcific aortic valvular stenosis, operated

216

1440

1.46

6.57

4.3

3.8

—

Cerebral palsy and other paralytic syndromes

422

1.89

6.57

3.4

4.0

—

Other diseases of oesophagus

366

1.96

6.57

3.4

3.8

—

Benign neoplasm of other and unspecified endocrine glands

494

1.81

6.56

4.7

4.1

—

Care involving use of rehabilitation procedures

185

2509

0.68

6.52

3.8

3.7

—

Postzoster neuralgia

3.59

6.49

4.1

4.8

—

Allergic bronchopulmonary aspergillosis (ABPA)

15.18

6.49

10.1

2.7

—

Use of disulfiram, acamprosate or naltrexone

266

2.12

6.48

2.9

4.3

—

Endometriosis

183

703

1.53

6.47

2.9

3.0

—

Adverse effects, not elsewhere classified

122

743

1.65

6.45

3.7

3.9

—

Pollen allergy

112

658

1.69

6.45

3.1

3.5

—

Disorders of muscles

334

1.99

6.44

4.8

4.2

—

Diabetic nephropathy

115

682

1.68

6.41

3.5

3.7

—

Acute lymphadenitis

178

2.38

6.38

7.4

4.2

—

Chronic iridocyclitis

172

2.41

6.38

3.3

3.8

—

Other viral hepatitis

172

2.41

6.37

2.7

3.9

—

Malignant neoplasm of breast, HER-negative

539

1.76

6.36

3.2

3.0

—

Brain glioblastoma and astrocytoma

5.26

6.36

3.3

5.5

—

Brain glioblastoma

6.09

6.35

3.3

4.3

—

Alcohol use disorder, ICD-based

260

1864

1.40

6.32

2.5

4.0

—

Other and unspecified follicular disorders

137

2.59

6.30

7.1

3.8

—

Other renal tubulo-interstitial diseases

3.39

6.30

3.5

4.4

—

Diabetic neuropathy

469

1.82

6.30

3.9

3.7

—

Other sleep disorders

379

1.91

6.28

3.3

4.5

—

Other and unspecified acquired haemolytic anaemias

5.22

6.27

8.3

4.0

—

Other and unspecified psoriasis

237

2.17

6.26

3.6

4.3

—

Disorders of myoneural junction and muscle in diseases classified elsewhere

6.53

6.25

3.1

3.2

—

Other disorders of bladder

473

1.81

6.24

4.0

4.3

—

Olecranon bursitis

218

2.22

6.23

3.4

4.2

—

Spinal instabilities

3.10

6.22

3.1

3.9

—

Lichen simplex chronicus and prurigo

212

2.24

6.21

3.4

4.0

—

Ulcerative ileocolitis

115

2.73

6.20

3.4

3.9

—

Scabies

452

1.82

6.19

3.3

3.8

—

Portal vein thrombosis

3.47

6.19

6.5

4.6

—

Haemophagocytic lymphohistiocytosis

17.92

6.17

8.0

4.3

—

Other mycoses, not elsewhere classified/unspecified

10.80

6.16

6.3

3.2

—

Pediculosis, acariasis and other infestations

201

2.26

6.09

4.1

4.4

—

Injuries to the elbow and forearm

437

2985

1.29

6.07

3.4

3.6

—

Ischaemic Stroke, excluding all haemorrhages

392

2229

1.31

6.06

3.6

3.8

—

Reactive arthropathies, FINNGEN

208

2.23

6.04

3.2

4.6

—

Somatoform disorder

544

1.74

6.03

3.4

4.1

—

Asthma, hospital admissions , main diagnosis only

514

3598

1.26

6.02

3.3

3.6

—

Allergic purpura

2.96

6.02

3.9

3.5

—

Benign neoplasm: Sigmoid colon

133

844

1.59

5.99

3.7

4.1

—

Erythema nodosum

3.02

5.98

2.2

3.3

—

Abnormal findings on diagnostic imaging of central nervous system

153

2.45

5.96

3.9

—

Atopic dermatitis

315

1919

1.35

5.96

3.4

—

Erosion of teeth , including avohilmo

137

876

1.57

5.96

2.8

3.6

—

L02BG Aromatase inhibitors

180

1219

1.48

5.95

2.3

3.7

—

Other arrhythmias

365

2089

1.32

5.94

3.8

3.6

—

Medicines for HER+ breast cancer

213

1412

1.43

5.94

2.3

3.7

—

Clear cell adenocarcinoma of kidney

112

2.71

5.93

4.1

2.9

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

110

591

1.66

5.93

2.6

3.2

—

Primary hyperparathyroidism

430

1.83

5.93

3.2

4.3

—

Postprocedural disorders of digestive system, not elsewhere classified

118

2.67

5.92

3.5

4.1

—

Mental and behavioural disorders due to alcohol

318

2286

1.34

5.92

2.5

3.9

—

Occupational exposure to risk-factors

124

2.62

5.91

7.2

5.2

—

Biological medicines for asthma

3.46

5.90

1.7

3.8

—

Small fibre neuropathy

107

2.76

5.89

6.7

4.7

—

Enteropathic arthropathies

3.33

5.89

2.4

4.6

—

Other and unspecified injuries of ankle and foot

130

2.57

5.88

3.5

4.0

—

Other specified disorders of kidney and ureter

107

2.75

5.88

5.4

4.4

—

Visual field defects

319

1.96

5.82

3.9

—

Mental and behavioural disorders due to sedatives or hypnotics

205

2.21

5.82

1.8

3.8

—

Syphilis

2.91

5.81

2.0

3.7

—

Syphilis

2.91

5.81

2.0

3.7

—

Spondylolisthesis/Spondylolysis

121

757

1.61

5.80

3.2

4.1

—

Duodenal ulcer

448

1.80

5.78

2.9

4.0

—

Selective deficiency of immunoglobulin G [IgG] subclasses

5.83

5.78

4.9

2.7

—

Malignant neoplasm of heart, mediastinum and pleura, including Hilmo

4.95

5.77

5.8

2.7

—

Idiopathic pulmonary fibrosis

342

1.92

5.74

4.8

4.4

—

Emotional disorders starting during childhood or adolecense, excluding more controls

117

2.61

5.69

4.4

3.3

—

Other bursopathies

495

1.75

5.66

2.8

4.2

—

Severe visual impairment, binocular

6.89

5.66

4.2

5.4

—

283

1920

1.36

5.65

5.5

3.7

—

Ovarian dysfunction

163

2.35

5.65

2.9

3.1

—

Disease of hard tissues of teeth, NOS

335

1312

1.34

5.65

3.4

3.6

—

Complications following infusion, transfusion and therapeutic injection

3.61

5.64

2.4

3.9

—

Artificial joint re-operation

268

2.04

5.63

2.8

4.2

—

Scoliosis

302

1.97

5.63

2.5

4.2

—

Infarction of spleen

6.15

5.63

10.2

3.7

—

Discitis, unspecified

3.47

5.62

2.6

3.8

—

Systemic disorders of connective tissue in diseases classified elsewhere

10.64

5.62

5.5

3.7

—

All dysplastic lesions of the vagina

3.23

5.61

2.5

3.2

—

Other infective otitis externa

189

2.24

5.61

3.4

3.5

—

Inflammatory diseases of prostate (prostatitis)

504

1.74

5.61

2.9

3.9

—

Oxicams

147

539

1.55

5.59

3.8

4.9

—

Malignant neoplasm of corpus uteri

202

2.19

5.59

2.4

3.1

—

Follow-up examination after treatment for malignant neoplasms

289

1.98

5.58

3.1

3.3

—

Pustular psoriasis

152

2.40

5.57

2.5

3.7

—

Striking against or struck by other objects

197

1378

1.43

5.54

3.5

3.8

—

Crowding of teeth, including avohilmo

283

1.91

5.53

4.0

3.1

—

Benign neoplasm: Caecum

440

1.79

5.53

4.0

4.1

—

Vasomotor and allergic rhinitis

207

1435

1.42

5.53

3.3

3.6

—

Dermatopolymyositis (FG)

3.70

5.52

4.9

4.8

—

Thrombotic microangiopathy

7.39

5.51

6.5

3.6

—

Other chondrocalcinosis

3.57

5.51

4.2

—

KRA_PSY_EATING, excluding more controls

183

2.24

5.50

3.3

3.1

—

Pediculosis, acariasis and other infestations

567

1.68

5.49

3.4

3.8

—

Systemic sclerosis (FG)

3.18

5.49

3.3

4.2

—

Artrosis, including avohilmo

515

2245

1.26

5.49

3.4

3.8

—

Superficial injury of hip and thigh

575

1.68

5.48

4.5

4.3

—

Malignant neoplasm of oesophagus

3.51

5.47

1.8

4.0

—

Malignant neoplasm of breast, ER-negative, including Hilmo

103

598

1.65

5.45

3.1

2.9

—

Orchitis and epididymitis

341

1.89

5.44

3.9

—

Malignant neoplasm of bone and articular cartilage of limbs

9.62

5.37

2.2

2.6

—

Lupus nephritis

11.88

5.36

3.9

4.5

—

Speech disturbances, not elsewhere classified

350

1.87

5.36

2.8

3.8

—

Paraplegia, diplegia of upper limbs

2.97

5.34

4.6

3.9

—

Ischemic heart diseases

541

2617

1.24

5.33

3.8

3.7

—

Other forms of systemic lupus erythematosus

5.58

5.29

2.7

4.4

—

Major coronary heart disease event

557

2721

1.24

5.26

3.9

3.8

—

Specific personality disorders

120

768

1.57

5.25

2.6

3.5

—

Intracranial and intraspinal abscess and granuloma

3.74

5.25

5.9

3.4

—

Colon adenocarcinoma

331

1.88

5.24

2.5

3.2

—

Malignant neoplasm of corpus uteri, including Hilmo

241

2.05

5.24

2.3

3.1

—

Fracture of skull and facial bones

130

848

1.54

5.24

3.2

4.2

—

Amputation of ankle bones

2.93

5.22

2.6

3.6

—

Erythema multiforme

2.93

5.22

3.4

4.0

—

Meningitis

163

2.29

5.22

3.7

4.0

—

Late syphilis

3.56

5.22

2.2

3.4

—

Temporomandibular joint disorders, including avohilmo

228

1632

1.38

5.21

2.9

3.3

—

Golimumab

2.91

5.20

2.4

3.4

—

Other and unspecified effects of external causes

158

1076

1.47

5.18

3.7

—

Personal history of medical treatment

4.99

5.17

11.7

2.8

—

Separation of retinal layers (serosa)

145

2.37

5.17

4.0

4.6

—

Ménière disease

369

1.83

5.16

4.0

4.1

—

Disorder of lipoprotein metabolism, unspecified

555

1.67

5.15

3.2

4.3

—

Polyarteritis with lung involvement [Churg-Strauss]/EGPA

8.85

5.15

3.5

3.0

—

Unspecified misadventure during surgical and medical care

203

2.14

5.15

2.6

4.4

—

Schizophrenia, schizotypal and delusional disorders

175

1217

1.44

5.14

3.0

3.7

—

Chronic myeloid leukaemia

8.79

5.14

4.9

3.9

—

Pulmonary eosinophilia, not elsewhere classified

3.85

5.13

6.3

3.9

—

Cholecystectomy

437

2998

1.26

5.10

3.8

3.6

—

Schizophrenia or delusion

174

1211

1.44

5.10

3.0

3.7

—

Primary ovarian failure

4.52

5.07

2.2

3.6

—

Dermatopolymyositis

3.48

5.06

4.9

5.1

—

Gonarthrosis, primary, with knee surgery

377

2345

1.28

5.06

3.4

3.9

—

Mental and behavioural disorders due to use of other stimulants, including caffeine

3.20

5.05

1.9

2.2

—

Scabies

153

2.31

5.04

3.9

4.1

—

Isolated proteinuria

2.73

5.03

3.1

3.7

—

Kela reimbursement Agammaglobulinemia (D80-84)

5.18

5.00

3.4

3.5

—

Personal history of other diseases and conditions

335

1.85

5.00

3.5

2.9

—

Heartburn

366

1.81

4.98

3.3

4.4

—

Other benign neoplasms of skin

233

1713

1.36

4.97

4.0

3.7

—

Monoarthritis, not elsewhere classified

123

2.46

4.97

4.4

4.0

—

Viral infections of the central nervous system

233

2.03

4.95

4.8

3.9

—

Other disorders of penis

374

1.80

4.95

3.5

4.1

—

Skin changes due to chronic exposure to nonionizing radiation

264

1823

1.34

4.95

5.7

3.6

—

Benign neoplasm of meninges

397

1.78

4.92

4.3

4.1

—

Chronic rhinitis, nasopharyngitis and pharyngitis

183

1295

1.42

4.91

3.3

3.7

—

Campylobacter enteritis

2.81

4.90

3.3

4.1

—

Diabetic retinopathy, excluding more controls

163

622

1.48

4.90

3.8

3.2

—

Percutaneous Coronary Intervention

515

2557

1.24

4.88

4.0

3.8

—

Viral infections of the central nervous system

248

1.99

4.88

4.7

3.9

—

Status post-ami

202

1103

1.40

4.88

3.8

—

Tuberculosis, IBD comorbidity

255

1.98

4.88

4.5

4.0

—

Any event in hilmo or specialist outpatient

+∞

4.87

5.2

0.0

—

Cardiomyopathies, Primary/intrinsic

480

1.70

4.87

3.7

3.8

—

Other or unspecified common variable immunodeficiency

9.60

4.87

3.7

5.0

—

Myocardial infarction

339

1844

1.30

4.86

3.4

3.8

—

Other noninflammatory disorders of uterus, except cervix

125

547

1.55

4.85

3.8

3.2

—

Malignant neoplasm of adrenal gland

9.48

4.85

4.7

4.4

—

Allergic contact dermatitis

451

1.72

4.83

2.7

3.7

—

Tubulo-interstitial nephritis, not specified as acute or chronic

215

2.06

4.83

2.8

4.1

—

Other obstructive and reflux uropathy

131

2.39

4.82

5.3

4.8

—

Chronic hepatitis, not elsewhere classified

113

2.51

4.81

2.7

3.9

—

Leiomyosarcoma, including Hilmo

6.65

4.81

1.8

4.2

—

Non-small cell lung cancer, squamous, helper endpoint

189

2.14

4.80

2.6

4.3

—

Disorders of adult personality and behaviour

143

971

1.48

4.79

2.6

3.7

—

Malignant neoplasm of nasal cavity and sinuses, including Hilmo

5.87

4.79

7.2

3.8

—

Paralytic strabismus

271

1.94

4.78

4.0

4.1

—

Right bundle-branch block

138

2.35

4.77

4.3

3.7

—

Nonalcoholic fatty liver disease

328

1.84

4.76

2.4

4.0

—

Malignant cancer of tonsil and base of tongue, including Hilmo

3.45

4.76

5.8

3.7

—

Viral hepatitis

223

2.03

4.76

2.6

3.9

—

Anti-inflammatory and antirheumatic products, non-steroids

187

658

1.43

4.76

4.0

4.8

—

Cardiomyopathy (excluding other)

491

1.68

4.75

3.7

3.8

—

Varicose veins

381

2268

1.27

4.75

3.9

3.6

—

Allergic rhinitis

167

1157

1.43

4.74

2.9

3.6

—

Hypoplasia of dental enamel, prenatal , including avohilmo

3.73

4.73

3.7

5.2

—

Hypermobility syndrome

120

2.44

4.72

1.5

3.6

—

Examination and encounter for administrative purposes

114

2.48

4.71

5.6

3.1

—

Open wound of wrist and hand

266

1966

1.33

4.71

3.8

—

Pleural plaque with presence of asbestos

337

1.83

4.70

6.1

4.4

—

Tonsillectomy and adenotomy

286

1511

1.32

4.69

3.1

3.5

—

Malignant neoplasm of endocrine gland

158

2.23

4.69

6.3

3.3

—

Late syphilis

3.17

4.67

2.4

4.0

—

Malignant neoplasm of heart, mediastinum and pleura

5.11

4.66

5.6

3.0

—

Polyarteritis nodosa

5.66

4.66

5.8

3.1

—

Irregular menses

218

1260

1.37

4.65

3.0

—

Malignant neoplasm of pancreas, including Hilmo

232

2.00

4.64

2.3

3.3

—

Keratitis

207

1512

1.37

4.64

3.6

3.8

—

Cardiomyopathy

111

721

1.55

4.62

3.6

3.9

—

Malignant neoplasm of tongue, including Hilmo

3.37

4.62

4.3

3.6

—

Embedded and impacted teeth

125

683

1.51

4.62

3.6

3.2

—

Acute laryngitis and tracheitis

347

1.79

4.61

4.1

3.2

—

Autoimmune hyperthyroidism

147

2.26

4.57

3.0

3.8

—

Mixed conductive and sensorineural hearing loss

482

1.67

4.55

3.8

4.4

—

Leiomyoma of uterus

322

1408

1.30

4.55

3.6

3.1

—

Secondary right heart disease

154

2.23

4.55

6.6

4.3

—

Asthma and opportunity respiratory infection

174

2.15

4.52

4.6

4.8

—

Malignant neoplasm of nasal cavity and sinuses

6.90

4.51

8.1

4.5

—

Tongue abnormality

228

1.99

4.51

4.4

3.9

—

Dentofacial anomalies [including malocclusion]

374

2382

1.26

4.49

3.2

3.5

—

Ovarian cyst

177

720

1.42

4.47

2.9

3.0

—

Coronary revascularization (ANGIO or CABG)

511

2559

1.22

4.46

4.0

3.8

—

Oesophageal obstruction

130

2.34

4.45

2.5

4.0

—

Primary adrenocortical insufficiency

4.17

4.45

3.1

—

Thyroiditis, unspecified

4.13

4.43

2.3

3.6

—

Pleural plaque

418

1.71

4.42

5.9

3.7

—

Hypoplasia of dental enamel, prenatal

5.10

4.41

4.0

—

Schizophrenia

540

1.62

4.41

2.7

3.8

—

Other sexually transmitted chlamydial diseases

143

2.25

4.40

3.3

2.9

—

Other disorders of the genitourinary system

502

1.64

4.40

4.1

3.9

—

Hyperfunction of pituitary gland

150

2.22

4.38

6.2

3.9

—

Systemic sclerosis

2.77

4.37

3.3

3.4

—

Gout due to impairment of renal function

3.43

4.37

4.0

3.8

—

Congenital iodine-deficiency syndrome/hypothyroidism

2.62

4.32

4.0

3.8

—

Actinic keratosis

253

1782

1.32

4.32

5.8

3.6

—

Other headache syndromes

222

1658

1.34

4.31

3.3

3.6

—

Toxic effects of substances chiefly nonmedicinal as to source

391

1.72

4.31

2.4

4.2

—

Other/unspecified reactive arthropathies

225

1.97

4.30

3.3

4.1

—

Lumbar disc prolapse

368

2246

1.26

4.29

3.3

3.7

—

Nonischemic cardiomyopathy

414

1.70

4.28

5.5

4.2

—

Systemic sclerosis, icd10

2.73

4.27

3.3

3.5

—

Left bundle-branch block

275

1.87

4.27

4.7

4.0

—

Obesity, other/unspecified

177

1279

1.39

4.27

2.3

3.8

—

Trochanteric bursitis

499

1.63

4.25

3.7

3.9

—

Malignant neoplasm of oesophagus, including Hilmo

2.64

4.24

1.7

3.2

—

Neuromuscular dysfunction of bladder

319

1.80

4.24

3.1

4.1

—

Nail disorders

283

1.85

4.23

4.3

4.2

—

Sudden idiopathic hearing loss

371

1.74

4.22

4.6

4.3

—

Hepatocellular carcinoma

3.18

4.22

2.7

3.2

—

Malignant neoplasm of accessory sinuses, including Hilmo

7.24

4.22

1.9

3.5

—

Leiomyosarcoma

7.13

4.20

2.0

5.1

—

Pilonidal cyst

241

1.92

4.20

3.7

4.1

—

Malignant neoplasm of eye and adnexa

7.10

4.19

2.6

3.7

—

Functional dyspepsia

149

1049

1.43

4.19

3.6

3.7

—

ILD and respiratory illness in diseases classified elsewhere

6.15

4.19

4.3

3.4

—

Osteopathy in diseases classified elsewhere

4.50

4.19

4.9

3.8

—

Alzheimer disease, including avohilmo

139

1395

0.70

4.18

4.6

3.7

—

Personality disorders

132

910

1.45

4.15

2.6

3.6

—

Other and unspecified diseases of blood and blood-forming organs

2.56

4.15

6.9

3.6

—

Subjective visual disturbances

148

1043

1.42

4.15

3.4

3.9

—

Spirochaetal infections, other/unspecified

180

1312

1.38

4.14

3.7

3.8

—

Other metabolic disorders

464

1.65

4.14

5.5

4.1

—

Polypectomy (DHB20)

250

0.28

4.14

2.1

4.5

—

Benign neoplasm: Transverse colon

434

1.67

4.13

3.0

4.2

—

Alcohol abuse, main dg, excluding more controls

495

1.62

4.13

1.9

4.1

—

Redundant prepuce, phimosis and paraphimosis

116

773

1.49

4.12

3.0

3.9

—

Unspecified nephritic syndrome

2.74

4.11

4.2

3.7

—

Chronic viral hepatitis

135

2.24

4.09

2.7

3.0

—

Paralytic ileus

129

2.27

4.07

3.4

3.7

—

Mixed hyperlipidaemia

155

2.15

4.07

4.7

4.4

—

Other and unspecified nonorganic psychotic disorders

607

1.55

4.06

3.4

3.6

—

Certolizumab pegol

3.38

4.06

3.6

3.4

—

Diabetic retinopathy

217

1008

1.35

4.06

3.7

3.3

—

Other spirochaetal diseases

180

1317

1.37

4.06

3.7

3.8

—

Osteosarcoma, including Hilmo

10.45

4.05

2.4

3.4

—

6.72

4.04

4.7

3.9

—

Lyme disease

178

1302

1.37

4.02

3.7

3.8

—

Injury of cranial nerves

5.75

4.02

7.4

3.2

—

Vascular disorders of the intestines

245

1.89

4.01

3.2

4.1

—

Malignant cancer of tonsil and base of tongue

3.94

4.01

6.3

4.4

—

Abnormal findings on examination of urine, without diagnosis

163

2.11

3.99

3.4

4.3

—

Malignant neoplasm of pancreas

183

2.04

3.99

2.3

3.1

—

Benign neoplasm: Adrenal gland

289

1.81

3.98

3.3

4.1

—

Other demyelinating diseases of the central nervous system

2.45

3.98

3.7

3.6

—

Calculus of lower urinary tract

218

1.95

3.97

3.6

4.4

—

Diabetic retinopathy, strict definition

112

665

1.49

3.97

3.6

3.5

—

Emphysema

275

1.83

3.96

3.7

4.9

—

Amenorrhoea

170

2.07

3.95

2.5

2.9

—

Other pulmonary heart/vessel disease

184

2.03

3.95

6.3

4.5

—

Burkitt lymphoma, helper endpoint

14.47

3.94

2.2

5.0

—

Other and unspecified mood [affective] disorders

184

2.02

3.93

2.3

3.6

—

Alcohol dependence

157

1130

1.39

3.92

2.5

4.2

—

Malignant neoplasm of tongue

4.12

3.91

4.8

3.8

—

Other noninflammatory disorders of cervix uteri

171

2.07

3.91

3.0

3.4

—

Other and unspecified nerve root and plexus disorders, also in other diseases

109

734

1.49

3.90

3.3

4.1

—

Myositis

2.53

3.90

6.0

4.8

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

178

2.03

3.89

1.9

3.6

—

Crossbite

282

1.78

3.88

4.9

3.5

—

Progressive systemic sclerosis

6.27

3.87

2.7

3.8

—

Other spirochaetal diseases

181

1337

1.36

3.86

3.7

3.8

—

Acne

284

1.80

3.86

3.6

3.0

—

Malignant neoplasm of accessory sinuses

9.41

3.85

1.7

4.9

—

Fenamates

332

1.62

3.84

4.2

4.7

—

Vitamin B12 deficiency anaemia

397

1.67

3.84

3.2

4.0

—

Disorders of optic nerve, not elsewhere classified

2.64

3.83

4.1

4.2

—

Actinomycosis

9.12

3.81

5.7

1.9

—

Use of glatiramer acetate

3.74

3.81

2.3

2.8

—

Actinomycosis

9.08

3.81

5.7

1.9

—

Tuberculosis, wide

286

1.80

3.81

4.5

4.2

—

Malignant neoplasm of oropharynx, including Hilmo

3.73

3.81

3.8

4.2

—

Pustulosis palmaris et plantaris

127

2.23

3.77

2.3

4.1

—

Other disorders of breast

422

1.64

3.77

3.4

3.6

—

Malignant neoplasm of rectum, including Hilmo

339

1.72

3.75

3.2

—

Thyrotoxicosis, other and/or unspecified

109

741

1.48

3.74

3.7

3.8

—

Intestinal malabsorption

154

2.10

3.73

3.0

3.9

—

Hydrocele

462

1.61

3.73

4.6

4.0

—

Fracture of shoulder and upper arm

218

1662

1.31

3.73

3.3

3.8

—

Malignant neoplasm of oropharynx

4.20

3.72

4.1

4.2

—

Coxarthrosis, primary

385

2659

1.23

3.71

3.8

—

Malignant neoplasm of bone and articular cartilage of other and unspecified sites

6.90

3.71

3.4

4.6

—

Disturbances of skin sensation

141

1007

1.40

3.71

3.0

3.5

—

Bitten or struck by other mammals

363

1.69

3.71

5.0

3.9

—

Unspecified mental disorder

212

1613

1.32

3.70

2.8

3.8

—

Lichen simplex chronicus

109

2.32

3.70

3.2

4.4

—

Degenerative diseases of the nervous system

134

1378

0.71

3.70

4.4

3.7

—

L02BX Other hormone antagonists and related agents

253

1.84

3.69

2.2

4.6

—

Fibrosarcoma, including Hilmo

5.76

3.68

1.7

4.9

—

Delivery

128

958

0.70

3.68

3.8

3.3

—

Persistent mood disorders

106

719

1.48

3.68

4.1

3.8

—

Necrosis of pulp, including avohilmo

313

2500

1.25

3.65

3.5

—

Complications following abortion and ectopic and molar pregnancy

2.44

3.65

3.4

—

Dermatophytosis

354

2872

1.23

3.64

3.8

3.6

—

Single spontaneous delivery

127

953

0.70

3.64

3.9

3.3

—

Bell's palsy

411

1.64

3.64

4.8

4.2

—

Blindness, monocular

3.82

3.63

4.2

4.7

—

Anorexia

3.56

3.63

4.6

4.1

—

Post-traumatic stress disorder

211

1.90

3.62

3.1

3.2

—

Impetigo

156

2.07

3.62

4.6

4.1

—

Drug-induced adrenocortical insufficiency

2.79

3.61

3.5

4.0

—

Malignant neoplasm of retroperitoneum and peritoneum, including Hilmo

3.77

3.61

2.9

4.4

—

Wet age-related macular degeneration

118

796

1.44

3.60

4.1

—

Waldenstrom macroglobulinemia, lymphoplasmacytic lymphoma

8.08

3.60

8.4

4.4

—

Drug-induced systemic lupus erythematosus

4.92

3.59

3.7

4.4

—

Deep endometriosis

299

1.75

3.58

2.3

3.6

—

Other leukaemias of specified cell type

6.63

3.58

19.6

4.1

—

Nonalcoholic steatohepatitis

4.88

3.58

1.6

4.9

—

Deep bite

401

1.60

3.58

3.0

3.8

—

Use of teriflunomide

4.85

3.57

1.8

4.4

—

Major coronary heart disease event excluding revascularizations

398

2173

1.22

3.57

3.6

3.8

—

Malignant neoplasm of cervix uteri

4.82

3.57

1.5

4.4

—

Other complications of labour and delivery, not elsewhere classified

242

0.34

3.57

2.1

2.7

—

Polyarthritis, unspecified

124

2.20

3.55

3.4

4.5

—

Status epilepticus

124

2.20

3.55

3.9

4.9

—

Nonorganic sleeping disorders, excluding more controls

611

1.51

3.55

2.9

3.7

—

Other meningitis

3.09

3.54

3.5

3.0

—

Alzheimer’s disease, strict definition

1034

0.66

3.54

4.0

3.7

—

Other diseases of spinal cord

105

2.31

3.54

4.9

4.7

—

Propionic acid derivatives

178

658

1.36

3.53

4.0

4.8

—

Fibrosarcoma

6.31

3.53

1.8

3.8

—

Varicella [chickenpox]

192

1.94

3.52

6.5

4.5

—

Dislocation, sprain and strain of joints and ligaments of shoulder girdle

162

1195

1.36

3.52

3.2

4.1

—

Other diseases of peritoneum

151

2.07

3.52

3.0

4.0

—

Other inflammation of eyelid

501

1.56

3.51

4.8

4.0

—

Carcinoma in situ of skin of other and unspecified parts of face

354

1.68

3.51

8.7

4.3

—

Malignant neoplasm of liver and intrahepatic bile ducts

2.72

3.50

3.0

3.4

—

Optic atrophy

2.65

3.49

7.8

4.1

—

Optic atrophy

2.65

3.49

7.8

4.1

—

Alzheimer’s disease (Late onset)

961

0.65

3.49

4.5

3.7

—

Open wound of ankle and foot

362

1.67

3.49

3.6

4.4

—

Social phobias

214

1.88

3.48

3.1

3.7

—

Superficial injury of ankle and foot

416

1.62

3.48

5.2

4.1

—

Varicella [chickenpox]

152

2.06

3.46

6.7

4.6

—

Intracranial injury

353

2725

1.23

3.46

3.5

3.7

—

Disorders of endocrine glands in diseases classified elsewhere

7.68

3.46

4.6

6.1

—

Covid-19 suspected case

108

746

1.45

3.44

4.1

3.6

—

Other mycoses, not elsewhere classified/unspecified

2.80

3.44

4.7

4.0

—

Other disorders starting during childhood or adolecense, excluding more controls

152

2.03

3.44

4.0

3.3

—

Dissociative [conversion] disorders

100

2.32

3.43

2.9

3.8

—

Disorders of magnesium metabolism

3.87

3.43

3.6

2.8

—

LSIL lesion of the vagina

3.57

3.42

2.5

3.3

—

Malignant neoplasm of testis, including Hilmo

3.56

3.41

5.8

3.1

—

Respiratory tuberculosis, bacteriologically and histologically confirmed

2.69

3.41

6.1

3.6

—

Cardiomyopathy in other diseases

5.18

3.41

3.9

4.8

—

Right hemicolectomy

245

1.81

3.41

2.7

4.1

—

Malignant neoplasm of eye and adnexa, including Hilmo

3.80

3.40

3.3

3.5

—

Bulimia nervosa (incl. atypical)

2.68

3.40

3.2

3.9

—

Benign neoplasm of mouth and pharynx

419

1.61

3.40

4.4

3.7

—

Papilloedema, unspecified

2.53

3.39

4.6

3.9

—

Use of fingolimod

5.10

3.39

2.2

4.5

—

Mouth breathing

141

1918

0.73

3.39

3.9

—

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

343

1.67

3.36

4.1

—

Atopic dermatitis, strict definition

147

1054

1.37

3.36

3.2

3.5

—

Tuberculosis

239

1.81

3.35

4.3

4.1

—

Other superficial injuries of ankle and foot

4.49

3.35

2.3

3.9

—

Other specified/unspecified nutritional deficiencies

4.47

3.34

5.7

4.4

—

Malnutrition

2.40

3.34

2.5

3.9

—

Cyclic neutropenia

9.20

3.32

6.3

5.6

—

ILD medications: pirfenidone

4.02

3.31

3.0

4.2

—

Arthropathy in Crohn disease

4.01

3.31

2.2

2.5

—

Malignant neoplasm of small intestine, including Hilmo

2.64

3.31

4.6

3.8

—

Benign neoplasm: Cerebral meninges

360

1.65

3.31

3.9

—

Malignant neoplasm of other and ill-defined sites, including Hilmo

3.69

3.30

3.3

3.7

—

Infective bursitis

102

2.28

3.30

3.0

4.8

—

Kela-code for severe mental illness

191

1460

1.31

3.29

2.8

3.8

—

Alcohol-induced chronic pancreatitis

226

1.83

3.29

2.2

4.7

—

Chondromalacia

2.32

3.28

2.2

3.6

—

Malignant neoplasm of rectum

270

1.75

3.28

3.4

—

ICD-8 DM (Sub-endpoint used for defining DM endpoints)

2.31

3.27

4.4

3.8

—

Disorders of puberty, all

2.82

3.27

4.4

5.2

—

Malignant neoplasm of larynx, including Hilmo

3.06

3.26

3.5

3.9

—

Malignant neoplasm of small intestine

3.06

3.26

4.0

3.3

—

Asthma and allergy, excluding more controls

274

1.73

3.26

3.0

2.7

—

Deviated nasal septum

188

1436

1.31

3.24

4.4

3.7

—

Tinnitus

133

966

1.38

3.23

3.7

4.0

—

Fibrosis of liver

3.92

3.22

4.1

4.2

—

Alzheimer disease

118

1203

0.72

3.22

4.7

3.8

—

Acquired absence of organs, not elsewhere classified

3.60

3.22

5.6

4.2

—

Hyperhidrosis

2.60

3.22

3.7

2.8

—

Implicit parasitic Sepsis

6.57

3.21

3.6

4.1

—

Other and unspecified nonscarring hair loss

5.46

3.21

1.4

3.1

—

Malignant neoplasm of tonsil, including Hilmo

3.84

3.20

4.1

4.4

—

Childhood asthma (age<16)

189

1.80

3.18

3.8

2.3

—

Childhood asthma (age<16), excluding more controls

189

1.80

3.18

3.8

2.3

—

Symptoms and signs involving the nervous and musculoskeletal systems

346

2848

1.22

3.17

4.0

3.6

—

Exfoliative dermatitis

3.32

3.17

6.4

4.0

—

Vulvovaginal ulceration/inflammation in other diseases

137

2.06

3.16

2.9

3.2

—

Acne vulgaris

207

1.84

3.16

2.5

2.9

—

Fall on and from stairs and steps

147

1089

1.35

3.16

4.0

4.1

—

Other eating disorders

137

2.06

3.16

4.0

3.5

—

Hyperkinetic disorders, excluding more controls

268

1.72

3.16

2.2

3.0

—

Use of amantadine

2.67

3.15

3.4

4.1

—

Benign neoplasm of other and unspecified female genital organs

124

2.11

3.15

2.4

3.5

—

Erosion and ectropion of cervix uteri

2.43

3.15

2.3

3.3

—

Excessive attrition of teeth

300

2437

1.23

3.15

3.7

3.5

—

Endometriosis of rectovaginal septum and vagina

244

1.77

3.14

2.4

3.2

—

Ingrowing nail

172

1.93

3.14

4.5

3.8

—

Failed induction of labour

124

2.11

3.14

2.7

3.3

—

Common variable immunodeficiency

4.13

3.12

3.4

3.8

—

Traumatic subdural haemorrhage

510

1.51

3.12

4.0

3.9

—

Other and unspecified injuries of shoulder and upper arm

105

2.21

3.10

3.7

4.0

—

Atypical facial pain

152

1.99

3.10

1.6

3.8

—

Malignant neoplasm of tonsil

4.06

3.10

4.3

4.7

—

Anosmia

3.71

3.09

4.1

1.7

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

216

1.81

3.09

3.5

4.6

—

Superficial injury of shoulder and upper arm

414

1.58

3.08

4.4

4.1

—

Paroxysmal tachycardia

110

650

1.42

3.08

3.9

3.6

—

Anaphylactic shock due to adverse effect of correct drug or medication properly administered

3.23

3.08

4.8

3.5

—

Primary coxarthrosis, bilateral

180

1380

1.31

3.07

3.3

3.9

—

Dementia in other diseases classified elsewhere

188

1.88

3.07

2.5

4.3

—

Chronic nephritic syndrome

139

2.03

3.07

5.9

4.2

—

Other hammer toe(s) (acquired)

597

1.46

3.06

3.6

3.7

—

Benign paroxysmal vertigo

172

1311

1.32

3.06

3.3

3.9

—

Other orthopaedic follow-up care

174

1.91

3.05

2.5

3.7

—

Rheumatoid lung disease

4.48

3.04

7.3

4.2

—

Cushing syndrome

3.40

3.04

4.8

4.0

—

Asthma and allergy

280

1.70

3.04

3.0

2.7

—

HSIL lesion of the vagina

3.39

3.03

2.8

3.7

—

Superficial injury of lower leg

133

977

1.37

3.03

3.3

3.9

—

Other extrapyramidal and movement disorders in other diseases

140

1038

1.35

3.02

2.8

4.0

—

Pure hyperglyceridaemia

2.38

3.00

4.2

4.9

—

Entropion and trichiasis of eyelid

339

1.63

3.00

4.8

4.6

—

Residual foreign body in soft tissue

154

1.96

3.00

3.0

4.5

—

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

120

2.10

2.99

5.1

3.8

—

Pemphigoid

107

2.18

2.98

4.3

4.5

—

Scleritis and episcleritis

197

1.84

2.98

3.5

3.9

—

Respiratory tuberculosis, confirmed

2.67

2.98

6.7

3.6

—

Aortic valve malfunction, age under 60 years

332

1.64

2.97

3.0

4.4

—

Malignant neoplasm of other and unspecified female genital organs, including Hilmo

2.66

2.97

1.8

2.4

—

Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue

3.33

2.96

7.8

4.2

—

Other disorders of central nervous system

3.30

2.95

3.1

3.2

—

Malignant neoplasm of floor of mouth, including Hilmo

4.80

2.94

5.6

3.5

—

Malignant neoplasm of other and unspecified parts of mouth, including Hilmo

4.80

2.93

1.9

3.6

—

Unspecified/other endometriosis

242

1.74

2.93

2.9

3.1

—

Disorders of puberty

2.86

2.93

2.7

5.1

—

Caries of enamel

501

3089

1.17

2.93

3.6

—

Emergency coronary revascularization (for ACS)

541

2823

1.17

2.93

4.0

3.8

—

Dependence on enabling machines and devices, not elsewhere classified

2.87

2.92

5.5

3.9

—

Thyrotoxicosis with diffuse goitre

476

1.52

2.91

3.5

4.0

—

Open wound of hip and thigh

108

2.15

2.91

4.2

3.8

—

Other degenerative diseases of the nervous system

159

897

1.33

2.91

3.8

3.7

—

Dislocation, sprain and strain of joints and ligaments of thorax

108

2.15

2.91

2.7

3.9

—

Emotional disorders and disorders of social functioning with onset specific to childhood

188

1.84

2.91

4.0

3.3

—

Hereditary hypogammaglobulinemia

5.62

2.91

2.7

3.0

—

Allergic contact dermatitis due to drugs in contact with skin

2.40

2.91

3.4

3.7

—

Lactose intolerance

2.23

2.90

1.8

4.3

—

Acute mastoiditis

3.78

2.90

3.3

3.1

—

Migraine

238

1539

1.26

2.90

2.5

3.4

—

Nummular dermatitis

296

1.67

2.90

3.2

3.8

—

Cervicalgia

117

849

1.38

2.90

3.2

3.8

—

Renal cell carcinoma of kidney

2.39

2.90

2.9

4.0

—

Ductal carcinoma of pancreas

5.50

2.89

1.3

4.2

—

Acute gastritis

266

1.70

2.88

3.3

3.7

—

Urethral stricture

214

1.79

2.88

4.7

4.3

—

Adenocarcinoma and papillary adenocarcinoma of stomach

2.61

2.88

1.3

3.6

—

Hyperprolactinaemia

2.26

2.87

6.4

3.1

—

Disorder of external ear, unspecified

109

2.13

2.85

2.7

4.2

—

Endometriosis ASRM stages 3,4

109

784

1.39

2.85

2.7

3.4

—

Benign neoplasm: Skin of other and unspecified parts of face

423

1.54

2.84

4.4

4.2

—

Other disorders of glucose regulation and pancreatic internal secretion

329

1.62

2.83

3.5

4.2

—

Blindness or visual impairment, binocular

4.60

2.83

3.1

4.1

—

Focal brain injury

208

1.79

2.82

4.9

—

Endometriosis of ovary

539

1.47

2.82

2.9

3.1

—

Malignant neoplasm of testis

3.37

2.82

5.0

3.1

—

Nephrotic syndrome

130

2.02

2.82

3.6

4.3

—

Pyoderma

2.43

2.82

4.7

4.1

—

Adult respiratory distress syndrome

2.69

2.81

5.1

3.7

—

Felty syndrome

4.05

2.81

5.9

3.7

—

Hydrocephalus in other diseases

4.04

2.81

4.9

3.7

—

Medullary cystic kidney disease, nephronophthisis

8.94

2.80

7.6

4.7

—

Kaposi sarcoma, including Hilmo

8.93

2.80

4.2

5.8

—

Other keratitis

377

1.57

2.79

3.2

4.3

—

Speech and linguistic disorders, excluding more controls

252

1.69

2.79

5.3

3.6

—

Disorders of psychological development

408

1.53

2.78

4.1

3.4

—

Memory loss

370

0.46

2.77

3.3

4.3

—

Malignant neoplasm of cervix uteri, including Hilmo

3.10

2.77

1.4

3.3

—

Benign neoplasm: Ascending colon

605

1.44

2.77

3.3

4.1

—

Adenocarcinoma, papilloma adenocarcinoma and mucinous carcinomas of rectum

277

1.67

2.76

3.3

—

Miliary tuberculosis

6.48

2.76

2.3

4.7

—

Other congenital malformations of the digestive system

201

1.79

2.76

3.7

4.6

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

418

1.54

2.76

5.0

4.2

—

Benign neoplasm: Connective and other soft tissue of thorax

5.17

2.76

4.3

3.2

—

Asthma, including avohilmo

728

3600

1.14

2.74

3.3

3.6

—

Other bacterial agents as the cause of diseases classified to other chapters

2.76

2.74

3.5

—

Emotional disorders starting during childhood or adolescence

165

1.87

2.74

4.4

3.6

—

Superficial injury of forearm

340

1.60

2.73

4.1

4.2

—

Universal erythroderma, KELA reimbursement

2.64

2.72

2.9

4.5

—

Eustachian salpingitis and obstruction

218

1.75

2.72

4.8

3.8

—

Sixth [abducent] nerve palsy

132

1.99

2.71

4.4

4.7

—

Appendectomy

343

2743

1.20

2.71

3.7

3.5

—

Dermatopolymyositis, unspecified

4.35

2.71

5.5

3.5

—

Malignant neoplasm of vulva, including Hilmo

3.50

2.70

2.2

3.2

—

Eating disorders

317

1.61

2.70

2.9

3.3

—

Impacted teeth

539

1.44

2.70

4.2

2.9

—

Adenocarcinoma and papilloma adenocarcinoma of rectum

264

1.67

2.69

3.2

—

Trigger finger

502

1.48

2.68

3.2

3.9

—

Other aneurysm

227

1.73

2.67

3.1

4.7

—

Respiratory conditions due to other external agents

2.36

2.66

5.4

3.9

—

Background retinopathy and retinal vascular changes

2.36

2.66

1.8

4.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

246

1.69

2.65

3.3

3.7

—

Eating disorder

242

1.70

2.65

3.3

3.1

—

Iridocyclitis in diseases classified elsewhere

2.42

2.65

2.2

3.5

—

Use of rivastigmine

707

0.62

2.64

2.9

4.1

—

Benign neoplasm: Tongue

106

2.10

2.64

7.3

4.2

—

Disorders of tooth development and eruption

405

1.48

2.64

3.2

3.4

—

Type 1 diabetes

135

1018

1.33

2.62

3.9

—

Implicit parasitic Sepsis

4.79

2.62

3.6

3.7

—

Bacterial meningitis

120

2.02

2.61

3.7

3.9

—

Tooth eruption problems

460

1.49

2.61

4.0

3.1

—

Congenital absence, atresia and stenosis of small intestine

7.84

2.61

1.6

5.7

—

Diabetic maculopathy, excluding more controls

392

1.54

2.60

3.0

4.1

—

Delayed milestone in childhood

133

1.93

2.60

2.0

5.1

—

Corneal ulcer

663

1.41

2.60

2.6

4.0

—

Liposarcoma, including Hilmo

4.07

2.58

2.8

3.6

—

Thyrotoxicosis

134

1014

1.33

2.57

3.6

3.8

—

Whooping cough

4.04

2.57

3.0

2.5

—

Dysplasia of cervi uteri

106

556

1.38

2.57

3.6

2.8

—

Other bacterial agents as the cause of diseases classified to other chapters

2.92

2.57

3.7

3.1

—

Suggestive for eosinophilic asthma

330

1.58

2.57

3.4

4.5

—

Otalgia

291

1.62

2.57

3.4

4.1

—

Supernumerary teeth EXCLUDE clefts and syndromes

5.61

2.56

1.5

7.6

—

Diplopia

499

1.47

2.56

5.6

4.0

—

Rash and other nonspecific skin eruption

362

1.55

2.56

6.5

3.8

—

Whooping cough

5.56

2.56

1.8

3.1

—

Aortic aneurysm

146

1098

1.31

2.55

3.3

4.0

—

Alcohol withdrawal state with delirium

253

1.67

2.55

1.9

4.4

—

Alcohol abuse, main dg

557

1.44

2.55

1.9

4.2

—

Morphin

2.63

2.54

1.8

4.6

—

211

0.38

2.53

2.9

—

Heart failure and hypertrophic cardiomyopathy

2.30

2.53

2.9

3.8

—

Exposure to uncontrolled fire in building or structure

3.54

2.50

2.2

3.1

—

Diabetes insipidus

3.53

2.50

3.8

3.5

—

Other benign neoplasms of uterus

187

1.78

2.49

2.5

3.5

—

Malignant neoplasm of other and unspecified parts of tongue, including Hilmo

3.00

2.49

1.8

4.3

—

Malignant neoplasm of other and unspecified parts of tongue

3.50

2.49

1.9

4.2

—

Disorders of plasma-protein metabolism, not elsewhere classified

3.89

2.48

11.5

4.5

—

Other peripheral vertigo

357

1.55

2.48

3.8

4.2

—

Testicular hypofunction

102

2.08

2.48

5.2

5.0

—

Mesothelioma

3.87

2.47

3.3

3.4

—

Superficial injury of wrist and hand

100

730

1.37

2.45

2.4

3.6

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

218

1.71

2.45

3.4

4.0

—

Dislocation, sprain and strain of joints and ligaments of knee

310

2393

1.20

2.44

3.1

3.6

—

Other enthesopathies

147

1136

1.30

2.44

3.2

3.7

—

Type 1 diabetes, wide definition, subgroup 1

106

781

1.36

2.43

3.6

3.8

—

Sequelae of injuries of lower limb

319

1.57

2.43

4.7

4.0

—

Female infertility, associated with anovulation

159

1.83

2.43

2.9

2.7

—

Scleritis

2.94

2.43

3.1

3.8

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

145

1.88

2.42

4.1

3.8

—

Cachexia

5.12

2.42

1.5

3.8

—

Lesion of ulnar nerve

489

1.46

2.42

4.0

—

Abscess of mediastinum

6.67

2.41

1.4

2.0

—

Cardiac arrest

173

1.74

2.41

2.4

3.4

—

Polycystic ovarian syndrome

110

2.01

2.40

3.3

—

Vitreous haemorrhage

376

1.52

2.40

5.2

3.9

—

Sequelae of injuries of head

182

1.77

2.40

2.8

4.7

—

Coronary atherosclerosis

403

2180

1.17

2.39

3.9

3.7

—

Pre-eclampsia superimposed on chronic hypertension

6.37

2.38

5.6

—

Oral leukoplakia, including avohilmo

2.08

2.38

3.8

4.0

—

Nosocomial condition (hospital)

4.22

2.38

2.1

4.1

—

Other and unspecified pemphigoid

3.10

2.38

4.0

3.6

—

Colitis, primary sclerosing

2.65

2.37

2.2

3.3

—

Peritonsillar abscess

675

1.38

2.37

3.5

3.9

—

Thoracic aortic aneurysm

625

1.40

2.36

3.7

4.1

—

Other superficial mycoses

2.28

2.35

4.3

3.4

—

Other symptoms and signs involving cognitive functions and awareness

279

2117

1.20

2.35

3.8

—

Other disorders of eyelid

264

2085

1.21

2.35

3.6

3.7

—

Family history of malignant neoplasm

322

1.56

2.34

3.2

—

Open bite

176

1.77

2.34

4.3

3.9

—

Vasculitis limited to skin, not elsewhere classified

2.11

2.34

4.7

3.6

—

Other congenital malformations of the digestive system

235

1.66

2.33

3.6

4.6

—

Other localized connective tissue disorders

2.33

2.32

6.2

3.6

—

Complications of other internal prosthetic devices, implants and grafts

140

1.87

2.32

3.6

3.9

—

Nonpyogenic thrombosis of intracranial venous system

3.27

2.32

8.3

4.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

235

1931

1.22

2.32

4.2

3.7

—

Mental and behavioural disorders due to cannabinoids

2.32

2.0

2.7

—

Benign neoplasm: Skin, unspecified

133

1.89

2.32

3.2

4.1

—

Carcinoma in situ of skin of trunk

126

1.92

2.32

9.3

4.2

—

Congenital malformations of ovaries, fallopian tubes and broad ligaments

126

1.91

2.30

4.2

3.6

—

Fluid overload

4.81

2.30

1.3

3.6

—

Glucosamine medication

296

1981

1.19

2.30

2.9

3.9

—

Disseminated intravascular coagulation [defibrination syndrome]

4.80

2.30

4.2

3.5

—

Dilated cardiomyopathy

503

1.44

2.30

3.8

4.5

—

Antenatal screening

388

0.64

2.30

2.3

2.7

—

Other and unspecified vasculitis limited to skin

2.14

2.30

4.9

3.6

—

Delivery, wide proxy

117

821

0.75

2.29

3.5

3.3

—

Invasive ventilation

302

0.46

2.29

4.6

4.2

—

Isolated proteinuria with specified morphological lesion

2.60

2.29

2.9

4.1

—

Arthropathy in ulcerative colitis

2.79

2.28

3.0

3.9

—

Other/unspecified enthesopathies of lower limb, excluding foot

215

1.68

2.28

1.9

4.4

—

Congenital malformations of the circulatory system

569

1.40

2.28

3.8

4.2

—

Other nonscarring hair loss

3.53

2.28

1.4

3.0

—

Superficial injury of head

134

1034

1.30

2.28

2.8

4.0

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

381

1.50

2.27

3.3

4.3

—

Other menopausal disorders

570

0.70

2.27

3.7

3.1

—

Other and unspecified rosacea

301

1.57

2.27

4.5

4.0

—

Benign neoplasm: Orbit, unspecified

3.98

2.27

3.6

2.7

—

Other osteochondropathies

231

1.65

2.26

3.8

4.1

—

Sequelae of injuries of neck and trunk

106

2.00

2.26

2.4

4.2

—

Episcleritis

156

1.81

2.26

3.4

3.8

—

Abnormal involuntary movements

530

1.42

2.25

3.4

3.9

—

Adenocarcinoma and ductal carcinoma of pancreas

2.17

2.25

1.3

3.4

—

Rheumatic heart disease, other

5.89

2.25

2.0

3.7

—

Short stature, not elsewhere classified

131

1.86

2.25

4.7

4.3

—

Barrett oesophagus

186

1.73

2.25

2.9

3.8

—

Prepatellar bursitis

149

1.82

2.24

3.3

4.1

—

Complications of cardiac and vascular prosthetic devices, implants and grafts

2.12

2.24

3.0

4.0

—

Mesothelioma, including Hilmo

3.14

2.23

3.0

4.8

—

Viral warts

104

777

1.34

2.23

3.4

3.5

—

Recurrent dislocation and subluxation of joint

179

1.74

2.22

2.2

4.5

—

Other/unspecified enthesopathies, not elsewhere classified

287

1.57

2.22

3.5

4.1

—

Other coagulation defects

248

1.62

2.21

3.9

3.5

—

Chronic suppurative otitis media

248

1.62

2.21

3.1

3.8

—

Fracture of forearm

306

2370

1.18

2.21

2.9

3.7

—

Agoraphobia

2.21

4.0

3.7

—

Drug-induced hypoglycaemia without coma

2.44

2.21

1.8

4.5

—

Umbilical hernia

152

1198

1.27

2.21

3.8

4.0

—

Other salmonella infections

114

1.94

2.21

4.6

4.3

—

Other and unspecified skin changes due to chronic exposure to nonionizing radiation

2.54

2.20

4.1

4.3

—

Other general symptoms and signs

127

1.88

2.20

3.1

3.2

—

Atlantoaxial subluxation

3.41

2.20

6.1

3.5

—

Salpingitis and oophoritis

634

1.38

2.19

2.5

3.5

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

180

1.73

2.19

7.6

4.0

—

Malignant neoplasm of renal pelvis, including Hilmo

3.38

2.19

6.6

3.2

—

Melanocytic naevi of trunk

409

1.47

2.18

3.3

3.8

—

Injury of blood vessels of thorax

4.43

2.17

3.3

—

Other dermatomyositis

4.39

2.17

4.0

4.4

—

Polymyositis

3.06

2.16

5.0

4.0

—

Exophthalmic conditions

3.04

2.16

3.0

4.4

—

Supernumerary teeth EXCLUDE clefts and syndromes, including avohilmo

2.82

2.15

1.3

6.7

—

Restless leg syndrome

510

1.42

2.15

3.3

3.8

—

Superficial injury of abdomen, lower back and pelvis

552

1.40

2.15

4.7

3.7

—

Contact with and exposure to communicable diseases

1091

0.73

2.14

3.6

3.3

—

Ectropion of eyelid

159

1.77

2.14

2.8

4.4

—

Abnormal serum enzyme levels

122

1533

0.77

2.14

4.3

3.9

—

Disorders in reading

2.39

2.13

7.7

4.0

—

Certain conditions originating in the perinatal period

299

1.52

2.13

3.9

3.5

—

Perichondritis of external ear

2.23

2.12

2.3

4.0

—

Volvulus

2.06

2.12

2.1

3.8

—

Benign neoplasm of eye and adnexa

404

1.47

2.12

3.2

3.9

—

Other contact dermatitis

275

1.57

2.11

3.4

3.5

—

Collapsed vertebra, not elsewhere classified

3.26

2.11

3.4

3.5

—

Carcinoma in situ of breast, intraductal

299

1.55

2.11

3.0

3.7

—

Prolapse and hernia of ovary and fallopian tube

122

1.88

2.10

3.7

3.6

—

Enthesopathies of lower limb, excluding foot

117

898

1.31

2.10

2.9

3.9

—

Other conditions related to polyarteritis nodosa

5.22

2.10

2.8

3.3

—

Lumbosacral plexus disorders

5.16

2.09

2.2

4.2

—

Embedded teeth, including avohilmo

260

1.58

2.08

2.0

3.3

—

Benign neoplasm: Spinal meninges

2.95

2.08

2.8

4.1

—

Other epidermal thickening

153

1.78

2.08

4.9

4.1

—

Carcinoma in situ of vagina

5.11

2.08

2.6

1.8

—

Procreative management

163

1086

1.25

2.08

3.1

3.6

—

Schizoaffective disorder

229

1.62

2.08

3.3

3.5

—

Marasmic kwashiorkor

4.23

2.08

1.8

3.4

—

Malignant neoplasm of other and ill-defined digestive organs, including Hilmo

2.73

2.07

1.2

3.5

—

Unspecified contracted kidney

3.58

2.07

10.9

3.8

—

Hypertension, portal

4.16

2.06

2.7

4.2

—

Other diseases of arteries and capillaries

341

1.50

2.06

3.4

3.9

—

Need for other prophylactic measures

222

1.63

2.06

6.6

4.1

—

Seronegative juvenile rheumatoid arthritis

2.34

2.05

3.0

5.1

—

Hypersensitivity angiitis

4.10

2.05

2.5

4.3

—

Precocious puberty

4.09

2.05

2.0

7.1

—

Wilms' tumor, including Hilmo

4.08

2.05

1.5

3.7

—

Malignant neoplasm of penis, including Hilmo

4.08

2.05

6.0

4.2

—

Other endocrine disorders

235

1.60

2.05

4.4

4.0

—

Other benign neoplasm of uterus: Other parts/unspecified

154

1.77

2.05

2.4

3.4

—

Valvular operations

617

1.37

2.04

3.8

—

Prurigo nodularis

2.07

2.02

1.9

3.5

—

Vitamin B12 deficiency anemia due to intrinsic factor deficiency

2.25

2.02

4.1

4.6

—

Chalazion

400

1.46

2.02

4.9

4.2

—

Ischaemic heart disease, wide definition

466

2531

1.14

2.02

3.9

3.8

—

Abdominal aortic aneurysm (AAA)

446

1.43

2.02

2.6

4.3

—

Benign neoplasm of brain and other parts of central nervous system

239

1.60

2.01

3.1

4.4

—

Burns and corrosions

500

1.40

2.01

2.9

4.0

—

Other and unspecified acne

2.66

2.01

7.8

3.9

—

Benign neoplasm: Vagina

2.85

2.01

2.1

3.4

—

Bullous disorders

224

1.62

2.00

5.4

3.9

—

Thyroiditis

224

1.61

1.99

2.9

3.9

—

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Leukocyte morphology finding [Identifier] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS